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P r e f a c e 
A great deal o f progress has taken place in b io log ica l ox idat ions and 
bioenerget ics since Oxidation and Phosphorylation edi ted by Rona ld 
W . Es tab rook and M a y n a r d E . Pu l lman (Vo lume X o f Methods in 
Enzymology) became avai lable i n 1967. T o update the mater ia l o r i g i -
nal ly t reated in this vo lume , f ive vo lumes on b iomembranes (Vo lumes 
L I I - L V I , Parts C - G , respect ive ly ) have been prepared , three deal ing 
w i t h b io log i ca l ox idat ions and t w o w i t h bioenerget ics. 
I n this v o l u m e , Part F o f " B i o m e m b r a n e s , ^ subt i t l ed k k Bioene rge t i c s -
Ox ida t i v e P h o s p h o r y l a t i o n , " we br ing together new methodo logy on 
the prepara t i on o f organelles, membranes , A T P synthetase complexes , 
and pur i f i ed components re levant to the subject ; the measurement o f 
A T P synthesis and regulat ion; the measurement o f t ransmembrane po-
tent ia l and in t rami tochondr i a l p H ; and the d issoc ia t ion and reconst i -
t u t i o n o f energy-transducing membranes . 
We are pleased to acknowledge the good counsel o f the members o f 
o u r A d v i s o r y Board for these five vo lumes . Special thanks are also due 
D r s . E. Cara fo l i , G. Palmer, H . Penefsky, and A . Scarpa f o r the i r 
he lp fu l comments on our out l ines fo r these vo lumes . Va luab le counse l 
f o r this v o l u m e was also p rov ided by Drs . D . E . Green , R H a r o l d , P. 
H i n k l e , R. K a b a c k , P. Pedersen, E . Racker , D . R. Sanadi , C. Schnai t -
m a n , T . P. Singer, W. Stoeckenius, A . Tzagolo f f , and J . R. W i l l i a m s o n . 
W e were ve ry grat i f i ed by the enthusiasm and coopera t ion o f the par-
t i c ipants i n the f i e ld o f b io log ica l ox idat ions and bioenerget ics whose 
adv ice , c omments , and cont r ibut i ons have enr iched and made possible 
these vo lumes . The f r i end ly cooperat ion o f the staf f o f Academic Press 
is grate fu l ly acknowledged . 
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[18] P r e p a r a t i o n o f Neurospora crassa M i t o c h o n d r i a 
By W A L T E R S E B A L D , W A L T E R N E U P E R T , and H A N N S W E I S S 
The fungus Neurospora crassa represents a eukaryo t i c cel l w i t h high 
b iosynthe t i c act iv i t i es . Cel l mass doubles in 2-4 hr du r ing exponent ia l 
g r o w t h , even in simple salt media w i t h sucrose as the sole carbon source. 
T h e mic roorgan ism forms a myce l i um o f long hyphae dur ing vegetative 
g r o w t h . The m i t ochondr i a can be isolated under re la t ive ly gentle condi ­
t ions since a few breaks in the thread l ike hyphae are suf f ic ient to cause 
the ou t f l ow o f the organelles. Th is art ic le describes t w o methods for the 
phys i ca l d i s rupt i on o f the hyphae: (1) The cells are opened in a g r ind mi l l 
be tween t w o ro ta t ing c o r u n d u m disks . Th is is a cont inuous and fast 
procedure and al lows large- and small-scale preparat ions o f m i t ochondr i a . 
(2) Hyphae are g round w i t h sand in a mor ta r and pestle. Th i s procedure 
can be appl ied to microscale preparat ions o f m i t o chondr i a s tar t ing w i t h 
m inu t e amounts o f cel ls. Other procedures for the i so la t ion o f Neuro­
spora m i t ochondr i a after the phys ica l d i s rup t i on or the enzymat ic deg­
rada t i on o f the cel l wa l l have been descr ibed e lsewhere . 1 
C u l t i v a t i o n o f Ce l ls 
Neurospora crassa w i l d type is g r o w n at 25° in VogeFs m in ima l 
m e d i u m plus 2% sucrose. 2 - 3 The i n o c u l u m is 1-2 χ 10 6 con id ia per 
m i l l i l i t e r . 
Cul tures o f 50 ml are shaken in 200-ml Er l enmeye r flasks on a ro ta to ry 
shaker at about 150 r p m under steri le cond i t i ons . Larger cu l tures , 0.5-8 
l i t e r s , are aerated in bott les w i t h a centra l in let tube under steri le con-
1 J . W. Greenawalt, D. O. Ha l l , and O. C. Wallis, this series, Vol . 10 [27]. 
2 H . J . Vogel, Microb. Genet. Bull. 13, 42 (1956). 
3 R. H . Davis and F. J. de Serres, this series, Vo l . I7A [4]. 
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C o p y r i g h t © 1979 b y A c a d e m i c P r e s s . I n c . 
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di t ions. F o r large-scale g r o w t h o f cel ls, 100 l i ters o f cu l ture m e d i u m are 
inoculated in a plastic t r ough w i t h 8 l i ters o f a cu l ture that was g r o w n f o r 
about 20 hr . The cells are aerated through a centra l in let tube . I t is not 
necessary to steri l ize the t r o u g h , the m e d i u m , and the air . 
The g r o w t h per iod is 14-24 hr for al l three types o f cu l tures . H y p h a e 
g row exponent ia l ly up to 20-24 hr . The cells are harvested by filtration 
on filter paper or l inen . Large amounts o f cu l ture med ium are centr i fuged 
in a laundry- type spin dr i e r th rough a bag o f l i nen . The cells are washed 
w i t h d is t i l l ed water . The y ie ld o f cells is 5-20 g wet weight per l i t e r 
cu l ture med ium. One g ram wet weight corresponds to about 100 mg d r y 
weight o r 40-50 mg p ro t e in . Fo r special purposes the cells can be f rozen 
and stored at -20° 
D i s r u p t i o n o f the C e l l Wa l l s 
A l l operat ions are per fo rmed at 0°-4°. The iso lat ion med ium consists 
o f 0.25 Μ sucrose, 1 mM E D T A , and 10 mM Tr is-acetate, p H 7.2. 
Grind Mill (Large- and Small-scale Preparation).4 The filtered cells 
are resuspended in 5-10 vo lumes (w/v) o f iso lat ion med ium by a 60-sec 
homogenizat ion in a k i t chen blender. The suspended cells are d i s rupted 
in a g r ind m i l l (F ig . 1) between t w o ro ta t ing c o r u n d u m disks. The ce l l 
suspension is poured in to a reservo i r and is d r i ven by centr i fugal force 
through the gr ind ing wheels. The homogenate is co l lected in the case and 
f lows through the out le t tube. 
F igure 1 shows the sect ion o f a g r ind m i l l const ructed for large-scale 
preparat ions . W i t h this mode l a f l ow rate o f 10-12 liters/hr is obta ined at 
a g r ind ing pressure o f 0.1-0.15 k i l opound/cm 2 . F o r small-scale prepara­
t ions a m i l l can be bu i l t i n w h i c h al l parts are reduced in size by a fac tor 
o f about 3. 
Sand and Mortar (Microscale Preparation). The filtered ce l ls , 0. Ι ­
Ο.5 g wet we ight , are m i x ed w i t h an equal we ight o f quartz sand (washed 
and ca lc inated , reagent grade) i n a mor tar ( inner d iameter 4-5 cm ) . One 
v o l u m e (v/w) o f i so lat ion m e d i u m is added, and the m i x tu r e is g r ound 
w i t h a pestle un t i l a smooth paste is obta ined (about 2 m in ) . A n o t h e r 
v o lume o f med ium is added, and the g r ind ing is cont inued for a fu r the r 
2 m i n . F ina l l y , the homogenized s lurry is transferred w i t h 2 vo lumes o f 
i so la t i on med ium into microcentr i fuge tubes o f 1.4 m l (Fa. Eppendor f f , 
H a m b u r g , Germany ) . 
4 H . Weiss, G. von Jagow, M. Klingenberg, and T. Bücher, Eur. J . Biochem. 14, 75 
(1970). 
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F I G . I . Section of the grind mi l l . The upper (D) and lower (E) grinding wheels consist 
of corundum (Edelkorund 89 A60 M5 V, Fa. Tyrol i t , Schwaz, Austria). The upper wheel 
(D) is glued into the round plastic disk (C) made from hard polyvinyl chloride. The reservoir 
(A) is a tube of Plexiglas 30 cm long and is screwed into the disk (C). The lead rings (B) 
have a weight of 2 kg each. The holding device for the lower wheel (E) is the screw (F), 
which fits exactly into the central hole. The screw (F) has on the bottom side a square 
bore, which fits to the end of the movable shaft (J). On its upper side the screw carries a 
stirrer. The shaft (J) rotates in the ball bearings ( I , K) and is protected from moisture by 
the covering (G) and the gasket (H). The case (L) is made from hard polyvinyl chloride. 
The shaft (J) is connected by means of the flexible coupling (M) to the electric motor (N) 
not shown in the figure (1300 rpm; at least 150 W). The diameter of the case is 180 mm. 
The lower grinding wheel is rotated by the electric motor. Its central hole is closed by a 
holding device. The upper grinding wheel does not rotate and can be li fted. Its central hole 
is open and connected with the reservoir cylinder. The upper grinding wheel is pressed 
against the lower wheel by the lead weights. The grinding area is reduced by a conical cut 
of the lower surface of the upper wheel. 
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The ef f ic iency o f the d i s rup t i on procedures can be checked by i n ­
spect ion in a phase-contrast microscope . The empty cells appear da rk , 
whereas the broken cells are br ight and show part icu late cel l con ten ts . 4 
I s o l a t i o n o f M i t o c h o n d r i a 
The m i t ochondr i a are isolated f r o m cells d is rupted by e i ther o f the 
t w o methods described above b y di f ferent ia l centr i fugat ion between 1200 
g (10 min) and 8000 g (30 m in ) . The low-speed sediment is usual ly 
comple te l y colorless. The high-speed centr i fugat ion may also be per­
f o rmed at 15,000 g for 15 m i n . W h e n " m i t o c h o n d r i a " are isolated f r o m 
f rozen cells the t ime for high-speed centr i fugat ion is doub led . The crude 
m i t ochondr i a l f rac t ion is resuspended in iso la t ion med ium (10% o f the 
s tar t ing vo lume ) , and the low- and high-speed centr i fugat ions are re­
peated. Fo r the microscale preparat ion o f m i t o chondr i a the microtubes 
can be used in a preparat ive refr igerated centr i fuge w i t h appropr iate 
adaptors . 
The y ie ld o f m i t ochondr i a is 2-3 mg/g wet weight o f cel ls. A b o u t 25 
% o f the tota l m i t ochondr i a are isolated, w h i c h corresponds to 4 - 6 % o f 
to ta l ce l lu lar p r o t e i n . 4 
Prope r t i e s o f I s o l a t ed N e u r o s p o r a M i t o c h o n d r i a 
Respiratory Chain and Oxidative Phosphorylation. The mi tochondr ia 
isolated by means o f the gr ind m i l l show a high rate o f resp irat ion w i t h 
py ruva te plus malate, succinate, N A D H , and N A D P H , wh i ch is fa i r ly 
we l l coupled to ox idat i ve phosphory la t i on . Three phosphory la t i on steps 
are i nvo l v ed in the ox ida t i on o f pyruva te , and t w o are invo l ved in the 
ox i da t i on o f succinate, N A D H , and N A D P H . 4 Rotenone, a n t i m y c i n , and 
K C N inh ib i t the e lectron f l ow at the k n o w n steps. O l i g omyc in , v en tur i -
c i d i n , and d i c y c l ohexy l ca rbod i im ide (DCCD) inh ib i t m i t ochondr ia l A T P ­
ase ha l f -max imal l y at 0.2, 0.2, and 1 μglmg m i t o chondr i a l p ro t e in , re­
spect ive ly .The molar rat io o f cy tochromes aa%> c, c i , b-^2-> and b-^% is 
1.0:2.9:1.0:0.9:0.9. The content o f c y tochrome aa3 is 0.24-0.34 jutmol/ 
mg m i t ochondr i a l p r o t e i n . 5 
In Vitro Protein Synthesis. The m i tochondr i a synthesize prote ins at 
a rate o f 5-10 p m o l leucine incorporated per minute and mi l l i g ram m i ­
t ochondr ia l p r o t e i n . 6 The leucine inco rpora t i on is in the same range as 
that observed w i t h m i t ochondr i a isolated after enzymat ic degradat ion o f 
5 G. von Jagow, H. Weiss, and M. Klingenberg, Eur. J . Biochem. 33, 140 (1973). 
6 A. von Ruecker, S. Werner, and W. Neupert, FEBS Lett. 4 7 , 290 (1974). 
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the cell w a l l , 7 but it does not exceed 4 -8% o f the inco rpora t i on rate 
observed in vivo in intact cel ls . The in vitro synthesis o f c y tochrome 
oxidase subunits cou ld be demons t ra t ed . 6 
Isolation of Mitochondrial Components. The m i t ochondr i a have been 
used as s tar t ing mater ia l f o r the iso lat ion o f c y tochrome ox idase , 8 ' 9 cy­
tochrome b,10,11 ATPase comp lex and Fx ATPase , 1 2 ' 1 3 ca rboxya t rac ty l o -
s ide-binding p r o t e i n , 1 4 and r i bosomes 1 5 and for the separat ion o f outer 
and inner m e m b r a n e . 1 6 The prote ins can be prepared f r om mi tochondr i a 
labeled homogeneously w i t h rad ioact ive amino ac ids . 1 7 This offers the 
advantage that pro te in is de termined by rad ioac t i v i t y measurements. 
The cy tochromes and F t ATPase can be prepared f r o m cells f rozen 
for several weeks at -20° . The complete subunit pat tern o f the F ! ATPase 
is obta ined on ly when m i t o chondr i a have been isolated in the presence 
o f the protease i nh ib i t o r pheny lme thy l su l f ony l f luor ide ( PMSF ) . The 
presence o f proteinase in the m i t o chondr i a l preparat ion is largely due to 
the co iso lat ion o f prote inase-conta in ing ves ic les . 1 8 M i t o chondr i a can be 
freed o f the proteinase vesicles by sucrose density gradient centr i fuga­
t i on . ^ M i t o c h o n d r i a " isolated f r om frozen cells are largely free o f this 
proteinase, since the proteinase vesicles are d isrupted by freeze-thaw-
i n g . 1 H 
Immunoprecipitation. For biogenetic s tud ies , 1 7 membrane-bound en­
zyme complexes can be isolated by immuno log i ca l techniques. Neuro­
spora m i t ochondr i a are a lmost comple te ly dissolved by T r i t o n X-100. 
F r o m the lysate, c y t ochrome ox idase , 1 9 a free subuni t o f c y t ochrome 
ox idase , 1 9 and the ATPase c o m p l e x 1 2 , 1 3 have been immunoprec ip i t a t ed 
by means o f specific ant isera. I n these studies the microscale preparat ion 
o f m i t o chondr i a has been appl ied to smal l amounts o f cells h ighly labeled 
by in vivo i nco rpora t i on o f radioact ive amino ac ids . 1 7 
7 W. Sebald, Τ. Bücher, Β. Olbrich, and F. Kaudewitz, FEBS Leu. 1, 235 (1968). 
8 H . Weiss, W. Sebald, and T. Bücher, Eur. J . Biochem. 2 2 , 19 (1971). 
9 H. Weiss and W. Sebald, this series, Vol . 53 [ I I ] . 
1 0 Η. Weiss and Β. Ziganke, Eur. J . Biochem. 41 , 63 (1974). 
1 1 H . Weiss and B. Ziganke, this series, Vol . 53 [23]. 
1 2 G. Jackl and W. Sebald, Eur. J . Biochem. 54, 97 (1975). 
1 3 W. Sebald and G. Wi ld , this volume, Article [41]. 
1 4 M. Klingenberg, Η. Aquila, P. Ricchio, Β. B. Buchanan, W. Eiermann, and H . Hack­
enberg, in "E lec t ron Transfer Chains and Oxidative Phophorylation" (E. Quagliariello 
et al., eds.), p. 431. North-Hol land Publ., Amsterdam, 1975. 
1 5 W. Neupert, G. Hallermeyer, and R. Michel, this series, Vo l . 56 [8]. 
1 6 W. Neupert and G. D. Ludwig , Eur. J . Biochem. 19, 523 (1971). 
1 7 W. Sebald, S. Werner, and H . Weiss, this series, Vol . 56 [5]. 
1 8 R. Michel, A. L iebl , A. Hartmann, and W. Neupert, Hoppe-Seylers Z. Physiol. Chem. 
357,415 (1976). 
1 9 S. Werner, Eur. J . Biochem. 43, 39 (1974). 
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venturicidin and, 505, 506 
Adenosine triphosphatase (F,) 
assay of, 320, 324-325 
functions of, 297 
from N. crassa, 148 
nucleotide depleted, 377-378 
preparation, 378-379 
reaction with adenine nucleotides and 
analogs, 379-380 
preparation of, 720-722, 742-744 
properties of, 381 
proteoliposomes and, 761-762, 765, 771 
purification from rat liver mitochondria 
method of Catterall and Pedersen, 320-
324 
method of Lambeth and Lardy, 324-
327 
properties, 324, 327-328 
of rat l iver mitochondria 
characterization of crystals, 334-337 
purification and crystall ization, 333-
334 
reassociation with membrane factor co-
valently bound to a collagen mem-
brane, 744-746 
from a thermophilic bacterium 
assay methods, 781-782 
properties of TFl9 783-784 
purif ication of TF , , 782-783 
purif ication of TF , subunits, 784-785 
reconstitution of T F 0 F , from subunits, 
786-787 
reconstitution of TF , from subunits, 786 
subunit properties, 785 
submitochondrial particles and, 105, 108 
Adenosine triphosphatase (TF,), from a 
thermophilic bacterium, crystallization 
of, 372-377 
Adenosine triphosphatase inhibitor 
from Candida utilis mitochondria 
assay methods, 421-423 






release of, 400 
properties of, 383 
of rat liver mitochondria 
analytical procedures, 408-409 
final note, 413-414 
purification, 409-41 i 
general properties, 412-413 
Adenosine triphosphate 
assay of, 221 
brown adipose tissue mitochondria and, 
74, 77-78 
content 
of brain, 218 
of hepatocytes, 214 
of kidney cortex, 220 
of rat heart, 216, 217 
of rat liver, 213 
coupling factor and, 192 
cyanine fluorescence and, 579 
exchange reactions, 253-254 
measurement of, 258 
hydrogen ion extrusion and, 227 
hydrolysis during work-up, 238 
intramitochondrial, phosphorylation po-
tential of, 241-242 
1 8 0 content, reactions contributing t o , 256 




Pasteur effect and, 291 
Perchlorate and, 202 
potassium salt, dissociation constant, 237 
rate of labeling with submitochondrial 
particles, 249-250 
separation, 285, 287, 288 
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procedure, 251-252 
reagents and materials, 250-251 
submitochondrial particles and, 111, 112 
Adenosine triphosphate-adenosine diphos-
phate exchange, assay of, 285-286, 288 
Adenosine triphosphate-phosphate ex-
change 
assay of, 286-287, 288, 310-313 
ATPase inhibitor and, 404, 412 
DCCD and, 499 
OSCP assay and, 392 
preparation from E. coli 
assay, 358-359 
characteristics of, 360-363 
preparation of membrane particles, 
359-360 
reconstituted, 704 
activity of, 703, 705, 708, 709, 710 
TF 0 -F j activity, assay of, 365-366 
Adenosine triphosphate synthesis 
artificially imposed electrochemical 
potential of protons and, 367-368 
by light-stimulated purple membrane ves-
icles 
assay of ATP synthesis, 778-779 
assay o f membrane potential and pro-
ton gradient, 779-780 
principle, 777 
properties, 780 
reconstitution of vesicles, 777-778 
model reaction and, 538, 539 
rate of, 118 
reconstitution under an imposed pH gra-
dient, 746-748 
resolution and reconstitution, 736-737 
methods, 737-741 
steroid hydroxylation and, 10 
using K + concentration gradients, 666-
667 
cation fluxes mediated by carboxylic 
ionophores, 674-675 
dependence of energy transduction on 
the gradient, 672-673 
experimental procedure, 667-668 
general features, 669-670 
properties, 670-672 
summary, 675 
yield and reproducibil ity, 673-674 
Adenosine triphosphate synthetase 
DCCD and, 497, 499 
inhibition data 
interpretation, 473-474 
requirements for publishing, 474 
inhibitors 
availability, 474-475 
physical properties, 475-477 
types of, 472-473 
oligomycin and, 503 
organotins and, 508 
preparation of components, 718-722 
ATPase F „ 720-722 
membrane sector (F 0 ) , 718-720 
other coupling factors, 722 
proteolipid ionophore of, 414-421 
reconstitution from heart mitochondria 
assay methods, 711-712 
preparation of hydrophobic proteins, 
713-714 
reconstitution of vesicles, 714-715 
venturicidin and, 506 
Adenylate cyclase, testis mitochondria and, 
11 
Adenylate energy charge, see Energy 
charge 
Adenylate kinase 
A M P assay and, 208 
assay of, 285-286, 288 
energy charge and, 231, 232-233 
exchange reactions and, 258 
hepatoma mitochondria and, 88 
insect muscle mitochondria and, 23 
mitochondrial subfractions and, 94 
perchloric acid and, 201 
Adenylate pool, size of, 233 
Adenyl imidodiphosphate, 377 
attachment to ATPase F,, 379-380 
purification of, 379 
Adenylyl imidophosphate 
crystallization of ATPase TF, and, 373 
Adipose tissue 
brown 
carnitine i n , 221 
mitochondria of, 16-17, 65-78 
white, mitochondria of, 15-16 
ADP, see Adenosine diphosphate 
Adrenal cortex, mitochondria, 9-10 
properties of, 10-11 
Adrenal medulla, optical probes and, 573 
Adrenocorticotropin, adrenal mitochondria 
and, 10-11 
Adrenodoxin, mitochondria and, 10, 11 
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Affinity chromatography 
of BCFo-BCF,, 194 
of coupling factor, 189-190 
to separate right-side-out from inside-out 
particles, 114 





as ionophore, 441, 442 
Alanine 
assay of, 221 
content o f rat heart, 216 
Albor ix in , 446 
Alcaligenes faecalis, aureovertin and, 485 
Alcohol dehydrogenase 
oxaloacetate assay and, 207 
pyridine nucleotide assay and, 264, 265, 
267, 268, 269, 270 
Aldolase, phosphate assay and, 212 
Algae, disruption of, 135, 138 
Alka l i , ATPase inhibitor extraction and, 
409, 423-424 
Alternaria tenuis, tentoxin and, 492 
Alumina, efrapeptin purification and, 494 
Amines 
organic, lasalocid and, 446 
uptake of, 564 
Aluminum oxide, rhein purification and, 459 
Amino acid(s) 
assay for transport wi th intact M. phlei 
cells, 179-180 
composition o f ATPase inhibitors, 400, 
404 
composition o f ATPase proteins, 350, 351 
coupling factor Β and, 389, 390 
OSCP and, 397 
transport 
comparison o f ghosts and ETP, 186-187 
K + gradient and, 679 
transport in proteoliposomes 
preparation of proteoliposomes, 197 
reconstitution o f proline uptake, 197— 
199 
9-Aminoacridine, measurement of ΔρΗ and, 
229, 563, 564-565, 566, 567, 779, 780, 
781, 787 
/7-Aminobenzamidine, yeast cell disruption 
and, 416 
y-Aminobutyrate, content o f brain, 219 
4-Aminobutyrate transaminase, brain mito­
chondria and, 58 
9-Amino-6-chloro-2-methoxyacridine, ATP­
ase assay and, 801 
Aminovinyls, as optical probes, 573 
Ammonia 
assay of, 209 
extraction of OSCP and, 395 
submitochondrial particles and. 111, 112 
Ammonia-EDTA particles 
coupling factor Β assay and, 384 
nature of, 380 
preparation of, 385-386 
Ammonium ions 
content of brain, 219 
M. phlei ETP and, 186 
uptake, p H change and, 564 
Ammonium sulfate, transhydrogenase and, 
270 
Amphotericin B, phospholipid bilayers and, 
766 
Amplif ier, electrophysiological techniques 
and, 661 
8-Anilinonaphthalene 1-sulfonate, 574 
membrane potential and, 559, 571, 573, 
585, 694, 779, 780 
submitochondrial particles and, 112 
transhydrogenase assay and, 270 
Anions 
ATPases and, 301-302 
exchange, organotins and, 509 
lipophilic, ionophores and, 439, 448 
transport by mitochondria, 452-453 
Anoxia, rat heart metabolites and, 217 
Antenna complexes, reaction center proteo­
liposomes and, 760, 765, 771 
Antibiotics 
as ionophores, 442-443 
macrocyclic, as uncouplers, 471-472 
Antibody 
latent ATPase and, 192 
M. phlei membrane systems and, 186 
TFo-F, and, 370 
Ant imycin 
Crabtree effect and, 297 
cyanine dyes and, 693 
cytochrome b-c, region and, 461-462 
M. phlei membrane systems and, 185 
N. crassa mitochondria and, 147 
sources of, 462 
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Antiserum 
to ATPase, preparation of, 802 
coupling factor Β and, 390 
t o N . crassa ATPase, preparation of, 345-
346 
A particles, OSCP assay and, 392, 393 
Arginase, renal mitochondria and, 12 
Arsenate, Crabtree effect and, 296 
Arsenite, as uncoupler, 471 
Arteries, isolation of mitochondria from, 
60-61 
Ascites cells, optical probes and, 573 
Ascorbate 
cytochrome c reduction by, 110 
flow dialysis experiments and, 683, 685, 
686 
proline uptake by proteoliposomes and, 
197 
Ascorbate-TPD, amino acid transport and, 
186-187 
Asolectin 
preparation of suspension, 311, 316, 364 
reconstituted vesicles and, 371 
solution of, 759 
treatment of filters w i th , 589, 599 
Asparagine, assay of, 209 
Aspartate 
assay, 207, 221 
content 
of brain, 218 
of hepatocytes, 214 
of kidney cortex, 220 
of rat heart, 216 
of rat l iver, 213 
Aspartate aminotransferase 
a-ketoglutarate assay and, 206 
oxaloacetate assay and, 207 
purification of, 207 
Aspergillus niger, disruption of, 139 
Aspergillus oryzae, disruption of, 139 
Astasia longa, disruption of, 138 
Asymmetry, of bacteriorhodopsin planar 
membranes, 753-755 
Atebrin, M. phlei membrane systems and, 
185 
ATP, see Adenosine triphosphate 
Atractylis gummifera, labeling with 
[ 3 5S]sulfate, 520 
Atractyloside 
arylazido derivatives, 526-527 







cytosol A TP/A DP ratio and, 244 
derivatives 
criteria o f purity, 530-532 
preparation of, 524-527 





Auramine Ο, as optical probe, 573 
Aurovertin(s) 
ATPase and, 300-301, 302, 338, 343, 401 
chemical properties, 481 
comparative potencies, 483, 484 
as fluorescent probes, 485 
inhibitory effects 
on chloroplasts and bacteria, 483, 485 
on mitochondrial systems, 481-483 
preparation of 
analysis of extracts, 479 
growth conditions, 478-479 
isolation and purification, 480 
large-scale cultures, 479 
liquid chromatography, 480 
radioactive, 480-481 
small-scale cultures, 479 
structure, 478 
toxicology, 481 
Aurovert in Β, physical properties, 476 
Aurovert in D, physical properties, 476 
Axon , squid, optical probes and, 573, 580, 
581 
Azide 
crystallization of ATPase TFj and, 373 
inhibitory effects of, 516 
2-Azido-4-nitrophenol, complex V and, 315 
4-Azido-2-nitrophenylaminobutyry l -
atractyloside preparation of, 526-527 
structure of, 526 
Azo dyes, as optical probes, 573 
Azotobacter, transhydrogenase of, 272 
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Β 
Bacillus stearothermophilus, ATPase of, 
299 
Bacillus subtilis, efrapeptin and, 495 
Bacteria 
ATPase, isolation by chloroform method, 
341 
energy-conserving systems, aureovertins 
and, 483, 485 
thermophilic 
crystallization of ATPase (TF t ) f rom, 
372-377 
DCCD-sensitive ATPase from, 364-372 
phospholipid molecular species, 371 
transhydrogenase assay in , 263, 266. 269-
270 
Bacteriochlorophyll reaction center com­
plex, proteoliposomes and, 760, 762, 
764. 765, 768, 770, 771 
Bacteriorhodopsin 
light-dependent potential changes and, 
774-775 
liposomes containing, assay of photopo-
tentials from, 608-611 
membrane potential reconstitution and, 
587, 588, 592, 601 
photopotentials and, 420 
planar membranes containing 
device, 752-753 
membrane-forming mixture, 752 
problem of asymmetry, 753-755 
proteoliposomes and, 758-760, 762, 764, 
765, 768, 769, 770-771 
Bacteriorhodopsin sheets, association wi th 
planar black membranes, 772 
Bacteriorhodopsin vesicles, reconstitution, 
704, 707, 709, 710 
detergents and, 702, 704 
Barium, lasalocid and, 446 
Bathophenanthroline, iron (II ) or nickel ( I I ) 
chelates, 517 
Bathophenanthroline-Fe 2 +-chelate, ATPase 
and, 401 
Bathophenanthroline sulfonate, 517 
Beauvericin 
as ionophore, 442, 444 
structure of, 436 
Beef heart 
mitochondria 
ATPase inhibitor of, 402, 404, 405 
aureovertin and, 482 
DCCD-binding protein from, 428-429 
improved method for ATPase isolation, 
317-319 
isolation of, 385 
preparation in high yield, 46-50 
preparation of ATPase by chloroform 
method, 338-341, 342 
preparation of ATPase from, 304-308 
preparation of rutamycin-sensitive ATP­
ase from, 315-317 
purification of transhydrogenase from, 
276-283 
reconstitution of ATP synthetase of, 
711-715 
reconstitution of pyridine nucleotide 
transhydrogenase from, 811-816 
submitochondrial particles, aureovertin 
and, 482 
Beetles, flight muscles, mitochondria of, 
22-24 
Benzimidazoles, as uncouplers, 468 
Benzoquinone 
model redox reactions and, 543 
proline uptake by proteoliposomes and, 
197, 199 
Benzylidinemalononitriles, as uncouplers, 
468-469 
Bicarbonate 
Ft ATPase and, 328 
measurement of ΔρΗ and, 562 
Bioenergetic systems, ionophores and, 450-
454 
Bio-Gel A-0.5m, ATPase and, 345, 353 
Bio-Gel ΗΡΑ, subunit purification and, 355 
Bio-Gel P-6, replacement of guanidine by 
urea w i th , 784 
BioSil H A , phospholipid preparation and, 
717-718 
Bongkrekic acid 





chemical criteria of pur i ty , 529, 531-532 
extraction, 528 
ion-exchange chromatography, 529 
thin-layer chromatography, 529 
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Botrycidin, nature of, 502, 505 
Bovine serum albumin 
brown adipose tissue mitochondria and, 
70, 76 
complex V and, 315 
defatted, preparation of, 712, 722 
fatty acids and, 472 
intact cell oxidative phosphorylation and, 
175 
isolation o f mitochondria and, 4, 15, 16, 
17, 80-81, 86, 116 
microorganismal mitochondria and, 142 
mitochondrial incubation and, 7 
piericidin A and, 457 
rhein and, 459 
rotenone removal and, 455 
submitochondrial particles and, 107 
Brain 
isolation of mitochondria, materials and 
methods, 51-52 
metabolite content of, 218-219 
mitochondria 
of nonsynaptic origin, 17-18 
synaptosomal, 18 
Brij 35. M. phlei membrane systems and, 
185 
Bromolasalocid, code number, 445 
Bromthymol blue, internal pH and, 565 
Br-X-537A, 445 
Buffers 
hydrocarbon/water interface and, 773 
isolation o f mitochondria and, 4 
Butane-2,3-dione, 518 
Butyrate, measurement of ΔρΗ and, 562 
C 
Cadmium ions, as uncouplers, 471 
Calcarisporium arhuscula, aureovertin 
preparation from, 478-481 
Calcimycin, 445 
Calcium chloride, Keilin-Hartree prepara­
tion and, 125 
Calcium ions 
A23187 and, 449 
accumulation, respiration and, 8-9 
adrenal mitochondria and, 10, 11 
brown adipose tissue mitochondria and, 
76 
heart mitochondria and, 14 
lung mitochondria and, 20 
measurement of H +/site ratios and, 642, 
643, 648-649 
measurement of proton translocation and, 
635 
membrane potential and, 229 
phosphorylation potential and, 237 
reconstitution studies and, 709 
renal mitochondria and, 12 
smooth muscle mitochondria and 15, 62, 
64, 65 
transhydrogenase and, 270 
translocation, electrogenicity of, 639-640 
uptake, K + diffusion potential and, 673 
Calcium ion pump, reconstitution, 701, 702, 
704 
activity of, 703, 705, 708, 709 
phospholipids and, 701, 706 
Calcium ion/site ratio, measurement in res­
piring mitochondria, 649-650 
isotopic Ca + + - jump procedure, 650-652 
simple steady-state rate method, 652-655 
simultaneous determination of Ca + +/site, 
H +/site and H + / C a + + ratios, 655-656 
Calculations 
exchange reactions and, 258-261 
phosphorylation potential and, 236 
Calibration 
of calcium-sensitive electrode, 653-654 
of cyanine dye fluorescence, 691-692 
optical probes and, 581-585 
Candida utilis 
disruption of, 140, 141 
growth conditions, 423 
N A D H dehydrogenases 
piericidin A and, 457 
rotenone and, 456 
Carbodiimide 
physical properties, 477 
mitochondria, ATPase inhibitor of, 402, 
404, 405, 421-426 
spin-labeled 
availability and preparation, 500 
biological properties, 500-501 
structure, 500 
Carbohydrates, labeled, determination of 
internal water volume wi th , 549-550 
Carbon dioxide, Pasteur effect and, 294, 295 
Carbonylcyanide m-chlorophenylhydrazone 
complex V and, 315 
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cyanine dyes and, 579, 693 
hepatoma mitochondria and, 85 
model redox reactions and, 542, 543 
phosphate esterification and, 175 
proteolipid ionophores and, 419 
uncoupling activity, 465, 469-470 
Carbonylcyanide phenylhydrazone 
M. phlei membrane systems and, 186 
solubility of, 463 
sources and synthesis of, 469-470 
Carbonylcyanide p-tri f luromethoxyphenyl-
hydrazone 
ATPase inhibitor and, 407 
ATP-Pj exchange and, 360-363 
ATP synthesis and, 118 
measurement of proton translocation and, 
637 
transhydrogenase assay and, 273 
uncoupling activity, 465 
Carboxin 
succinate oxidation and, 460-461 
synthesis of, 461 
Carboxyatractyloside 
decarboxylation of, 523 
labeled 
extraction, 521 
purif ication, 521-522 
yield, 522 
Carboxyatractyloside-binding protein, from 
N. crassa, 148 
Carboxymethyl-cellulose 
factor Β and, 387-388 
purif ication of subunit 4 on, 355 
Carboxymethyl-cellulose C-25 
OSCP preparation and, 395 
TF j subunits and, 784 
Carboxymethyl-Sephadex C-50, colicin Κ 
and, 535 
Cardiolipin 
ATPase depletion of particles and, 111, 
112 
ATPase inhibitor and, 407 
of thermophilic bacterium PS3, 370 
molecular species of, 371 
Carnitine 
assay of, 211—212 
brown adipose tissue mitochondria and, 
74, 76 
incubation of mitochondria and, 8 
tissue content of, 221 
Carnitine palmitoyltransferase, brown adi­
pose tissue mitochondria and, 76 
Carotenes, electrochromism of, 557-558 
Carotenoids, as optical probes, 573, 585 
Catalase 
inhibitor, dextran 500 and, 131 
viscosity barrier centrifugation and, 133, 
134, 135 
Cations 
ATPase activity and, 795, 796 
ATP-Pj exchange and, 360-361 
fluxes mediated by carboxylic iono^ 
phores, 674-675 
ionophores and, 436-438 
polyvalent, lasalocid and, 446 
CCCP, see Carbonylcyanide /??-chlorophen-
ylhydrazone 
(-C-PR 
as ionophore, 443, 448 
structure, 441 
Cell(s) 
flow dialysis, 682-683 
intact, phosphorylation potential in , 243-
245 
internal volumes, 551 
new method for rapid separation from 
medium, 203-204, 205 
Cellophane disks, preparation for growth of 
N. crassa, 659 
Centrifugation 
differential, isolation of mitochondria 
and, 5-6 
gradient, isolation of mitochondria and, 6 
isolation of mitochondria and, 36-38, 43 
low-speed, of rat liver homogenate, 35 
Centrifuge(s), for separation of cells and or­
ganelles, 552 
Centrifuge tubes, cleaning of, 41 
Cesium chloride, separation into alkali and, 
205 
Cetyltrimethylammonium bromide, hydro­
carbon/water interface and, 773 
Charcoal 
nucleotide separation and, 251 
treatment wi th AMP, 251 
washing of, 250 
Chemiosmotic hypothesis, ionophores and, 
450-451 
Chloramphenicol 
cell starvation and, 169 
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cyanide-insensitive respiration and, 26 
electron transport and, 516 
Chloride ions 
E. coli ATPase and, 796 
permeation, oligomycin and, 504 
5-Chloro-3-/er/-butyl-2'-chloro-4'-nitrosali-
cylanilide 
complex V and, 315 
hepatoma mitochondria and, 85 
submitochondrial particles and, 108 
uncoupling activity, 465 
Chloroform 
isolation of ATPase and, 338, 345 
T F , extraction and, 782 
Chloroform-methanol 
DCCD-binding protein and, 428, 430, 431 
proteolipid extraction and, 417 
p-Chloromercuribenzene sulfonate, proline 
uptake and, 199 
p-Chloromercuribenzoate 
complex V and, 315 
M. phlei membrane systems and, 185 
p-Chloromercuriphenyl sulfonate 
complex V and, 315 
coupling factor Β and, 390 
4-Chloro-7-nitrobenzofurazan 
availabil ity, 488-489 
structure, 488 
Chlorophylls, electrochromism of, 557 
Chloroplasts 
ATPase of, 298, 299, 300 
isolation by chloroform method, 341, 
342 
Dio-9 and, 515 
efrapeptin and, 495 
energy-conserving systems, aureovertins 
and, 483 
fragments, water compartment of, 550-
551, 552 
internal volume, 551 
ionophores and, 449, 452. 453 
leucinostatin and, 514 
measurements of ΔρΗ in , 563 
membranes, optical probes and, 573 
Nbf-Cl and, 490 
onset o f ATP and ADP labeling in , 246-
247 
organotins and, 509 
quercit in and, 491-492 
spinach, ATPase inhibitor of, 402, 404, 
405 
Cholate 
a;solectin solution and, 759 
calcium ion pump and, 702 
complex V preparation and, 310 
cytochrome oxidase and, 699, 701, 749 
extraction of F 0 and, 719-720 
hydrophobic protein preparation and, 
713, 714 
M. phlei membrane fragments and, 195 
phospholipid solubilization and, 714 
preparation o f F, and membrane factor 
and, 743-744 
preparation o f TFo-F, and, 368 
purification o f BCF 0 and, 195 
rutamycin-sensitive ATPase and, 317 
solubilization of B C F Q - B C F ! and, 194 
submitochondrial particle fractionation 
and, 277 
transhydrogenase chromatography and, 
279 
transhydrogenase reconstitution and, 813, 
815 
treatment of ETP and, 193 
Cholate-dialysis procedure, reconstitution 
studies and, 701-703, 722-723 
Cholesterol, filter membranes and, 604 
Choline phosphotransferase, microsomes 
and, 101, 104 
assay of, 102 
Chromaffin granules 
ionophores and, 454 
measurement of ΔρΗ in , 563 
membrane potential, 555 
Chromatophores 
measurement o f ΔρΗ in , 563 
membrane potentials, 452 
Chromatophore photosynthetic redox chain, 
planar membranes and, 756 
Citrate 
assay of, 210-211, 221 
brain mitochondria and, 57 
coenzyme A assay and, 210 
content 
of brain, 218 
of hepatocytes, 214 
of kidney cortex, 220 
of rat heart, 216, 217 
of rat l iver, 213 
intact mitochondria and, 143 
Pasteur effect and, 291, 296 
yeast mitochondria and, 150 
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Citrate lyase, citrate assay and, 211 
Citrate synthase 
coenzyme A assay and, 210 
oxaloacetate assay and, 208 
Citreoviridin 
ATPase and, 343 
availability, 486 
bacterial systems and, 487 
fluorescence properties, 488 
inhibitory effects on mitochondrial sys­
tems, 487, 488 
physical properties, 476 
preparation 
analysis o f extracts, 486-487 
extraction, 486 
further purif ication, 487 
structure, 486 
toxicity, 487 
Citreoviridin monoacetate, physical prop­
erties, 476 
citric acid cycle intermediates 
assay 
methological update and correction, 
200-203 
new, modified and alternative methods 
for, 205-215 
brown adipose tissue mitochondria and, 
77 
mitochondria and, 7-8 
Clostridium pasteurianum, Dio-9 and, 515 
Coenzyme A 
content of rat liver, 213 
and derivatives, assay of, 209-211, 221 
hepatocyte content of, 214 
protection during hydrolysis, 202 
Coenzyme Q, see also Ubiquinone 
bacteriochlorophyll proteoliposomes and, 
760 
carboxamides and, 461 
piericidin A and, 456 
proteoliposomes and, 767-768 
rotenone and, 455 
2-theoyltrifluoroacetone and, 460 
Coenzyme Q-cytochrome c reductase, re­
constituted, activity of, 709, 710 
Colicins 
effects of, 532-533 
use of 
intact cells, 535-536 
membrane vesicles, 536 
Colicin E l , preparation of, 533 
Colicin I , purification of, 533 
Colicin Κ 
assay systems 
spot test, 533-534 
survival test, 534 
bacterial strain and media, 533 
purification of, 534-535 
Collagen membrane 
covalent binding of membrane factor and 
reassociation with F t , 744-746 
source of, 744 
Collodion f i lm, bacteriorhodopsin incorpo­
ration in , 601 
Complex I , preparation of, 716 
Complex V 
assay for ATPase reaction, 313-314 





activators and inhibitors, 315 
composition, 314-315 
purification procedure, 308-309 
Complexation selectivities, of neutral ion­
ophores, factors affecting, 440 
Continuous-flow apparatus, testing and per­
formance, 622 
Continuous-flow method, pH measurement 
by, 618-627 
Copper, Keilin-Hartree preparation and, 
123 
Copra, bongkrekic acid preparation and, 528 
Corrections, exchange reactions and, 259-
260 
Corticosteroidogenesis, adrenal cortex mi­
tochondria and, 10 
Corticosterone, formation of, 10 
Coupling 
brown adipose tissue mitochondria and, 
70 
tightness, criteria for, 225 
Coupling factor 
assay for activity, 190-191 
Keilin-Hartree preparation and, 126 
overview, 380-383 
Coupling factor A, nature of, 382 
Coupling factor Β 
properties of, 381 
purification 
A Ε particle preparation, 385-386 
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assay method, 384 
isolation procedure, 386-388 
mitochondrial isolation, 385 
other B-type factors, 391 
properties, 388-391 
Coupling factor F 3 , 383 
Coupling factor F 6 
assay of, 398-399 
preparation of, 399 
properties of, 381, 383 
Coupling factor-latent ATPase 
purification by affinity chromatography, 
189-190 
removal from ETP, 187 
solubilization, 189 
Coupling system, assay in heart mitochon-
dria, 48-49 
CP 38295, 446 
Crabtree effect, expression for, 296 
Creatine, content of rat heart, 217 
Creatine kinase 
heart mitochondria and, 14 
isolation of mitochondria and, 4 
Creatine phosphate content 
of brain, 218 
of rat heart, 216, 217 
Cristae, membrane 
electric capacitance of, 628 
proton conductance of, 629 
Crithiciia fasciculata, disruption of, 136-137 
Cross-reactivity, of ATPase inhibitors, 405 
Crown polyethers, 447 
Cyanide 
ATP synthesis via the K + gradient and, 
670-671 
cytochrome c reduction and, 110 
M. phlei membrane systems and, 185 
N A D H oxidase and, 266, 270 
N. crassa mitochondria and, 147 
Cyanine dyes 
adsorption to glass, 576 
membrane potentials and, 559, 571, 573, 
585-586 





optimization of procedure, 690-691 




studies with single cells, 695 
Cyclodepsipeptides, as ionophores, 441— 
442, 444 
Cycloheximide, use in flux studies, 664 
Cysteamine, uncoupling by CCP and, 469 
Cytidine triphosphate 
ATP-Pj exchange preparation and, 361 -
362 
separation of, 287-289 
Cytochrome(s) 
assay in bovine heart mitochondria, 49-
50 
brown adipose tissue mitochondria and, 
75 
of depleted ETP, 188 
detergent-treated ETP and, 193 
Keilin-Hartree preparation and, 123 
content of mitochondria 
brain, 59 
N. crassa, 26, 147 
plant, 25 
M. phlei ETP and, 184, 185 
M. phlei membrane fragments and, 196 
protoplast ghosts and, 182 
red-green, separation of, 309 
Cytochrome a, a:i, oxidation, proton release 
and, 624-626 
Cytochrome h 
measurement of, 668 
M. phlei ETP and, 184, 185 
from N. crassa, 148 
oxidation, proton uptake and, 627 
Cytochrome h-cx region, inhibitors of, 4 6 1 -
462 
Cytochrome /?-565, reduction, brown adi-
pose tissue mitochondria and, 72 
Cytochrome c 
cytochrome oxidase proteoliposomes 
and, 761 
intact mitochondria and, 143 
isolation of mitochondria and, 4 
Keilin-Hartree preparation and, 120, 124 
membrane preparations enriched i n , 109— 
110 
oxidation, proton release and, 624-626 
phosphorylation site and, 240 
proton translocation and, 751 
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removal from submitochondrial particles, 
114 
Cytochrome(s) c + ( j , redox changes, de-
termination of, 668 
Cytochrome oxidase 
hepatoma mitochondria and, 88 
inner membrane and, 101, 103 
Keil in-Hartree preparation and, 126 
as marker enzyme, 5 
membrane potential and, 595 
mitochondrial subfractions and, 94, 104 
of N. crassa, 26, 148 
planar membranes containing, 755-756 
proteoliposomes and, 761, 762. 765, 771 
reconstitution and, 699, 703, 706, 707, 
708, 709, 710 
of smooth muscle mitochondria, 62 
submitochondrial particles and, 109 
viscosity barrier centrifugation and, 133, 
134 
Cytochrome oxidase vesicles 
activity of, 703, 705, 709 
preparation of, 749 
Cytochrome P-450 
microsomes and, 101, 104 
assay of, 102 
mitochondria and, 10, 11, 117 
liver, 21 
renal, 12 
Cytosol, ATP/ADP ratio in , 243-244 
D 
DBCT, see Dibutylchloromethyl t in chlo-
ride 
DCC, see 3,4',5-Trichlorosalicylanilide 
DCCD, see Dicyclohexylcarbodiimide 
DDA, see Dimethyldibenzylammonium ion 
DE-3936, 445 
Density gradient centrifugation 
of BCFo-BCF,, 194 
M. phlei membrane fragments and, 195-
196 
of submitochondrial membrane frag-
ments, 108-109 
Deoxycholate 
ATPase isolation and, 332 
calcium ion pump and, 702 
complex V preparation and, 309 
cytochrome oxidase and, 699 
hydrophobic protein preparation and, 714 
preparation of F, and membrane factor, 
743 
Deoxycorticosterone, hydroxylation of, 10 
Deoxyribonuclease 
membrane preparation and, 782, 803 
protoplast ghost preparation and, 181 
Deoxyribonucleic acid, mitochondrial, size 
of, 9 
Desaspidin, uncoupling activity, 465, 472 
Detergents 
cationic, hydrocarbon/water interface 
and, 773 
reconstitution studies and, 707 
Detergent-dilution procedure, reconstitu-
tion studies and, 703-704 
Dextran, separation of mitochondria from 
medium and, 204 
Dextran 500, viscosity barrier and, 131 
W,A' 2-Diadenosyl pyrophosphate, forma-
tion of, 538 
Dialysis 
device for reconstitution experiments, 812 
reconstitution of vesicles by, 371-372 
stripped membrane particles and, 796 
vesicle reconstitution and, 715 
Diaminodipropylamine, reaction with Se-
pharose, 525 
Diaminodurene, model redox reactions and, 
543 
Dianemycin 
cation fluxes and, 675 
as ionophore, 443, 446 
Diazomethane, hazard of, 510 
Dibutylchloromethyl t in chloride 
availability and synthesis, 510 
biological properties, 511 
isotopically labeled, 511 
physical properties, 477 
Dibutylferrocene, model redox reactions 
and, 542, 543, 544 
3,5-Di-r<?/7-butyl-4-hydroxybenzylidine-ma-
lononitrile, see SF6847 
2',5'chloro-3-/i'/7-butyl-4'-nitrosalicylani-




carboxamides and, 461 
Keilin-Hartree preparation and, 126 
864 S U B J E C T I N D E X 
Dicoumarol , uncoupling activity, 465, 471 
Dicumaro l , M. phlei membrane systems 
and, 185, 186 
Ν, Ν '-Dicyclohexylcarbodiimide 
analysis, 496 
ATPase and, 302-303, 329-330, 333, 343, 
350 
ATP-P, exchange and, 360, 362 
availability, 495 
BCFo-BCF, and, 194, 195 
biological properties, 497-500 
chemical properties, 496 
complex V and, 315 
intrinsic membrane protein o f M. phlei 
and, 188 
N. crassa mitochondria and, 147 
physical properties, 477 
proteolipid ionophore and, 419 
stimulation of energy-linked functions by, 
502 
structure, 495 
submitochondrial particles and, 106 
toxicology, 496 
use of, 498, 500 
Dicyclohcxylcarbodiimidc-binding protein 
extraction and isolation 
from beef heart mitochondria, 428-429 
from E. coli, 429-434 




detergents and, 702, 703-704 
purple membrane vesicles and, 778 
of a thermophilic bacterium 
assay methods, 364-368 
preparation of T F 0 F , , 368-369 
properties of reconstituted vesicles, 372 
properties of TF 0 -F „ 369-370 
reconstitution o f vesicles, 370-372 
Dicyclohexyl- 18-crown-6 
as ionophore, 443 
structure of, 436 
Dierucoyl-L-a-phosphatidylcholine, trans­
hydrogenase reconstitution and, 814-
815 
Diethylaminoethyl-Bio-Gel A , ATPase pu­
rification and, 339-340 
Diethylaminoethyl-cellulose 
ATPase and, 345, 353 
ATPase subunits and, 806-807 
labeled atractyloside and, 523 
succinyl-atractyloside and, 524 
TFj purification and, 782-783 
T F i subunits and, 784-785 
Diethylaminoethyl-cellulose DE-23, ATP 
ase and, 341 
Diethylaminoethyl-cellulose DE-52 
ATPase and, 353, 791-793, 794, 804 
inhibitor, 424 
subunits and, 355 
bongkrekic acid and, 529 
coupling factor Β and, 387 
DCCD-binding protein and, 431-432 
preparation of TFo-F, and, 368-369 
Diethylaminoethyl-Sephadex A-25, ATPase 
and, 326 
Diethylaminoethyl-Sephadex A-50, prepa­
ration of, 306 
Diethylaminoethyl-Sepharose CL-6B, trans­
hydrogenase and, 277-278, 279 
Diethyl ether 
DCCD-binding protein and, 431 
proteolipid preparation and, 417 
Digitonin 
ATPase preparation and, 331 
cell disruption and, 243, 244 
purification of, 116 
treatment of mitochondria and, 117 
Diglycolamic acid le, structure, 441 
Dihydroxyacetone phosphate, assay of, 221 
5,6-Dihydro-2-methyl-l,4-oxathiin-3-car-
boxanilide, see Carboxin 
4.5- Dihydroxyanthraquinone-2-carboxy-
late, see Rhein 
1,25-Dihydroxycholecalciferol, renal mito­





by oxygen, 537 
phosphorylation coupled to, 537-539 
Dimethyldibenzylammonium ions 
membrane potential and, 678 
M. phlei ETP and, 186 
proline uptake and, 199 
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Dimethylformamide 
ionophores and, 448 
as uncoupler solvent, 464 
Dimethylglutarate, as buffer, 658 
5,5-Dimethyloxazolidine-2,4-dione, meas­
urement o f ΔρΗ and, 229, 681, 683, 684, 
685 
Dimethyl suberimidate, 518 
Dimethyl sulfoxide 
ionophores and, 448 
long-term storage o f mitochondria and. 
29, 31, 32 
as uncoupler solvent, 464 
2,4-Dinitrophenol 
ATPases and, 301, 302 
ATP synthesis and, 672 
complex V and, 315 
cyanine dyes and, 579, 693 
hepatoma mitochondria and, 84, 85, 88 
M. phlei membrane systems and, 186 
Pasteur effect and, 290 




biological properties, 514-515 
nature of, 473 
physical properties, 477 
structure, 514 
Dioleyl-L-a-phosphatidylcholine, transhy­
drogenase reconstitution and, 812-813 
4,4'-Diphenyl-2,2'-dipyridine, 517 
Diphenyl phosphorazidate, 516 
1,3-Diphenylpropane-1,3-dione, 517 
Diphosphatidylglycerol, amino acid trans­
port and, 188 
1,3-Diphosphoglycerate, inorganic phos­
phate assay and, 212 
3,3'-Dipropylthiodicarbocyanine iodide, 
availability of, 690 
Discarine B, 516 
5,5'-Dithiobis(2-nitrobenzoate), carnitine 
assay and, 211 
Dithiothreitol 
acyl-CoA hydrolysis and, 202 
coenzyme A and, 211 
D M B , see 5,5-Dimethyloxazolidine-2,4-dione 
DNP, see Dinitrophenol 
Dodecyl sulfate, dissociation o f immunopre-
cipitate by, 347 
Dog heart, mitochondria, characteristics of, 
45 
Donnan potentials, probe calibration and, 
584 
Dowex AG1-X4, separation of nucleotides 
on, 248-249, 251-252 
Driving block, continuous-flow pH meas­
urement and, 619-620 
Driving-mixing device. pH measurement 
and, 619-622 
DT-diaphorase, rhein and, 459 




ATPase and, 343 
availability and preparation 
analysis, 494 
growth conditions, 494 
isolation and purif ication, 494 
biological properties, 494-495 
physical properties, 476 
structure, 493 
EGTA 
heart mitochondria and, 43, 46 
mitochondrial incubation and, 7 
preparation of mitochondria and, 667 
Ehrlich ascites tumor cells 
Crabtree effect in , 296 
efficiency of Pasteur effect in , 293 
Electrical characteristics, of lipid-impreg-
nated filter membranes, 607-608 
Electrical potentials, assay across envelope 
vesicles and plasma membranes, 612 
Electric charge, generation by proteolipo­
somes associated with planar phospho­
lipid membranes, 770-771 
Electrode(s) 
calcium-sensitive, 652 
calibration o f probe signal and, 581 
glass, rapid proton-transfer reactions and, 
615 
ion-sensitive, measurement of proton 
translocation and, 631-632 
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ion specific 
measurement of membrane potential 
and, 5 5 6 
p H changes and, 5 6 4 
net K + and H + movements and, 6 6 8 
oxygen, measurement of proton translo­
cation and, 633 
reference, measurement of proton trans­
location and, 6 3 2 - 6 3 3 
Electrometers 
measurement of proton translocation and, 
633 
rapid proton-transfer reactions and, 6 1 5 -
6 1 6 , 6 1 9 
Electromotive force, estimation of, 5 9 2 - 5 9 5 
Electron microscopy 
of ATPases, 298 
of ATPase (TF!) from a thermophile, 3 7 3 , 
3 7 5 - 3 7 7 
of hepatoma mitochondria, 8 7 
mitochondrial integrity and, 144 
Electron transfer, reversed, OSCP assay 
and, 3 9 2 - 3 9 3 
Electron transport 
cyanide-insensitive, plant mitochondria 
and, 25 
tentoxin and, 4 9 3 
Electron transport particle 
amino acid transport, comparison to 
ghosts, 1 8 6 - 1 8 7 
depleted 
preparation, 187 
properties and reconstitution, 1 8 7 - 1 8 8 
detergent-treated, properties and recon­
stitution of, 1 9 2 - 1 9 3 
of M. phlei 
preparation, 182— 183 
properties, 1 8 3 - 1 8 5 
preparation of, 3 0 9 
Electrophoresis 
of ATPase, 3 0 8 
beef heart mitochondria, 3 1 9 
chloroform-solubilized, 3 3 8 
E. coli. 8 0 5 , 8 0 6 , 8 0 9 - 8 1 0 
Ν. crassa, 3 4 5 , 3 4 7 - 3 4 8 
oligomycin-sensitive, 3 3 3 
prepared by chloroform method, 343 
purified subunits, 3 5 6 
yeast, 353 
of atractylose and carboxyatractyloside, 
5 2 1 
of coupling factor B , 3 8 8 - 3 8 9 
of coupling factor 6 , 3 9 9 
of DCCD-binding protein, 4 3 1 , 4 3 2 , 4 3 4 
of OSCP, 3 9 6 - 3 9 7 
of T F O - F L 3 7 0 
of T F L E 7 8 3 - 7 8 4 
of transhydrogenase, 2 8 1 , 2 8 2 
Electrophysiological techniques 
for transport linked membrane potential 
growth and handling of cells, 6 5 8 - 6 5 9 
procedure, 6 6 1 - 6 6 2 
recording apparatus, 6 5 9 - 6 6 1 
Emericid, 4 4 5 
Energy charge 
measurement of responses to 
concentration of substrates, 234 
effects of metal ions and phosphate, 
2 3 3 - 2 3 4 
establishment of desired values, 2 3 2 -
2 3 3 
size of adenylate pool, 233 
presentation of results, 2 3 4 - 2 3 5 
relevance of, 2 2 9 - 2 3 2 
Energy conservation 
reconstitution, 7 1 5 - 7 1 6 
assay of oxidative phosphorylation at 
site I , 7 2 3 - 7 2 6 
assay of oxidative phosphorylation at 
site I I I , 7 3 1 - 7 3 2 
assay of transhydrogenase, 7 2 6 - 7 2 8 
conclusions, 7 3 5 - 7 3 6 
formation of phospholipid vesicles con­
taining complex I and ATP synthe­
tase, 7 1 6 - 7 2 2 
formation of vesicles by cholate-di-
alysis technique, 7 2 2 - 7 2 3 , 7 2 9 -
7 3 0 , 7 3 3 - 7 3 4 
formation of vesicles by cholate-dilu-
tion technique, 7 3 0 - 7 3 1 , 7 3 4 - 7 3 5 
formation of vesicles containing succin­
ate dehydrogenase, complex I I I , 
cytochrome c, cytochrome oxidase 
and, ATP synthetase, 7 3 2 - 7 3 3 
oxidative phosphorylation at site I , 7 1 6 
oxidative phosphorylation at site I I , 7 3 2 
oxidative phosphorylation at site I I I , 
7 2 8 , 7 2 9 
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Energy coupling, by submitochondrial 
membrane fragments, 108-109 
Energy-linked functions, DCCD and, 502 
Energy transduction, dependence on K + 
gradient, 672-673 
Enniatin A 
as ionophore, 442, 444 
transport and, 680 
Envelope vesicles, assay of electrical poten­
tials across, 612 
Enzymes 
of brain mitochondria, 17-18 
specific act iv ity, 58 
of hepatoma mitochondria, 82-84, 88 
of Keil in-Hartree preparation, 124 
marker 
distribution in submitochondrial 
subfractions, 93-94 
outer membrane and, 101 
relevance of adenylate energy charge to, 
229-232 
Equil ibrium constant, adenylate kinase and, 
232 
Equipment, measurement of proton trans­
location and, 629-633 
Erythrocytes, see Red blood cells 
Escherichia coli 
ATPase, 298, 299, 341, 342 
dissociation and reconstitution, 800-
810 
inhibitor of, 402, 404, 405 
ATP-Pj exchange preparation from 
assay, 358-359 
characteristics of, 360-363 
preparation of membrane particles, 
359-360 
cells, internal volume, 551 
colicin Κ and, 533 
cult ivat ion of, 165 
DCCD-binding protein 
preparation of unlabeled proteolipid, 
431-432 
preparation of labeled proteolipid, 429-
431 
purif ication of unmodified protein, 432-
434 
Dio-9 and, 515 
efrapeptin and, 495 
growth, adenylate pool size and, 233 
intact cells for P/O ratio determination 
assay, 169-174 
equilibration of starved cells wi th 3 2 P l 5 
169 
preparation of cells, 169 
measurement of ΔρΗ in , 563 
membrane potential, 452, 555 
membranes, optical probes and, 573 
membrane vesicles, transport using K + 
diffusion gradients, 676-680 
nicotinamide nucleotide transhydrogen­
ase of, 266, 270 
reconstitution of, 787-800 
organotins and, 509 
phage M 1 3 coa t protein, incorporation into 
liposomes, 703 
preparation of phosphorylating vesicles 
f rom, 165-166 
starved cell preparations, pertinent char­
acteristics, 174-175 
substrate uptake by, 453 
vesicles 
internal volume. 551 
membrane potential, 555, 559 
Ethanol 
ionophores and, 448 
oxaloacetate assay and, 207 
Pasteur effect and, 294, 295 
tissue extraction and, 202 
as uncoupler solvent, 464 
yeast mitochondria and, 150, 151, 159 
Ethidium, as optical probe, 573 
Ethidium bromide, 516 
l-Ethoxycarbonyl-2-ethoxy-1,2-dihydroqui-
noline, 515 




proteolipid and, 429 
Sepharose coupling to A DP and, 190 
Ethylenediamine tetraacetate 
ATPase and, 201 
isolation of mitochondria and, 4, 12-13 
mitochondrial incubation and, 7 
submitochondrial particles and, 106-107 
iV-Ethylmaleimide, 518 
acetyl-CoA assay and, 210 
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measurement of proton translocation and, 
638, 642, 646, 648 
proline uptake and, 199 
ETP, see Electron transport particle 
Euglena gracilis, disruption of, 138 
Exchange reactions, uncouplers and, 463 
F 
Fatty acid(s) 
content of brown adipose tissue mito­
chondria, 75 
incubation of mitochondria and, 8 
long-chain, as uncouplers, 472 
oxidation 
by brown adipose tissue mitochondria, 
75-76 
Pasteur effect and, 296 
spin-labeled, coupling to atractyloside, 
527 
of thermophilic bacterium PS3, 370, 371 
Fatty acyl carnitine, tissue content of, 221 
Fatty acyl coenzyme A 
brown adipose tissue mitochondria and, 
75 
content 
of rat heart, 217 
of rat liver, 213 
Fatty acyl coenzyme A dehydrogenase, of 
brown adipose tissue mitochondria, 76 
Fatty acyl coenzyme A synthetase, brown 
adipose tissue mitochondria and, 76 
FCCP, see Carbonylcyanide /?-trifluorome-
thoxyphenylhydrazone 
Fermentation 
ATP formation and, 293 
oxygen and, 290 
Ferredoxin, renal mitochondria and, 12 
Ferricyanide 
Keil in-Hartree preparation and, 126 
proline uptake by proteoliposomes and, 
197 
reduction, measurement of, 542 
Ficol l , isolation of mitochondria and, 6 
Filters, phospholipid-impregnated, proteo­




assay of electrical potentials across, 612 
assay of photopotentials, 608-611 
electrical characteristics, 607-608 
preparation, 605-608 
summary, 613 
Fi l trat ion, isolation of mitochondria and, 5 
FITC-dextran, internal pH and, 566 
Flavins 
Keilin-Hartree preparation and, 123 
M. phlei ETP and, 184, 185 
Flavin adenine dinucleotide, complex V 
and, 315 
Flavoprotein, brown adipose tissue mito­
chondria and, 75 
Flies, flight muscles, mitochondria of, 22-
24 
Flow dialysis 
for determination of ΔρΗ and active 
transport, 680-682 
calculation of ΔρΗ. 686-688 
method, 682-686 
measurement of ion distribution and, 556 
measurement of pH changes and, 564 
Fluorescein, as optical probe, 573 
Fluorescence 
amine uptake and, 564-565 
ATPase-bound aurovertin and, 301 
aureovertins and, 485 
of energized vesicles, measurement of, 
366 
of ETP with ANS, 183 
Fluoroalcohols, as uncouplers, 470 
l-Fluoro-2,4-dinitrobenzene, 517 
Fluorometers 
cyanine dyes and, 690 
enzymatic assays and, 200-201 
Fluorometry, pyridine nucleotide assay and, 
267, 269 
Flux techniques, for transport l inked mem­
brane potential 
preparation of cells, 663-664 
procedure, 664-666 
Freeze-thaw 
dissociation of ATPase and, 806 
reconstitution experiments and, 707 
French pressure cell 
cell disruption by, 165, 360, 790 
fractionation of mitochondria and, 90-93 
Fructose-1,6-diphosphate 
assay of, 221 
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inorganic phosphate assay and, 212 
Pasteur effect and, 291 
Fructose 6-phosphate, Pasteur effect and, 
291 
Fumarase, brain mitochondria and, 58 
Fumarate 
assay, 207 
content of brain, 218 
Fumarate hydratase, latency, intact mito-
chondria and, 143 
Fungi, filamentous, disruption of, 135, 139-
140 
Fusion procedure, reconstitution studies 
and, 709 
G 
ß-Galactosidase, induction, DCCD and, 498 
Galegine, M. phlei membrane systems and, 
186 
Glass beads 
homogenization and, 4 
yeast cell breakage and, 152-153, 154-
155, 162-163 
Glassware, cleaning of, 41 
Glucose 
assay of, 221 
ATPase inhibitor and, 425 
Crabtree effect and, 296, 297 
disappearance, measurement of, 294-295 
growth o f E. coli and, 165 
inorganic phosphate assay and, 212 
Glucose carrier, reconstitution of, 707 
Glucose-1-phosphate 
A M P assay and, 209 
inorganic phosphate assay and, 212 
Glucose-6-phosphatase, assay of, 102 
Glucose-6-phosphate 
A M P assay and, 209 
assay of, 221 
inorganic phosphate assay and, 212 
Pasteur effect and, 291 
Glucose-6-phosphate dehydrogenase 
GTP assay and, 208 
inorganic phosphate assay and, 212 
P/O ratio and, 226 
pyridine nucleotide assay and, 267 
Glutamate 
assay of, 221 
brain mitochondria and, 57 
content 
of brain, 219 
of hepatocytes, 214 
of kidney cortex, 220 
of rat heart, 216 
of rat liver, 213 
Glutamate dehydrogenase 
ammonia assay and, 209 
α-ketoglutarate assay and, 206 
pyridine nucleotide assay and, 267 
Glutamate dehydrogenase (NAD) , brain mi­
tochondria and, 58 
Glutamate dehydrogenase (NADP) , brain 
mitochondria and, 58 
Glutamate-oxaloacetate transaminase, brain 
mitochondria and, 58 
Glutamate transport 
colicin and, 536 
by M. phlei, 186, 187, 188, 193 
Glutaminase 
phosphorylation potential determination 
and, 237 
renal mitochondria and, 12 
Glutamine 
assay of, 209 
content 
of brain, 219 
of kidney cortex, 220 
transport by M. phlei, 186, 187, 188, 193 
Glutamine synthetase 
glutamine assay and, 209 
phosphorylation potential determination 
and, 237 
Glutathione reductase, pyridine nucleotide 
assay and, 264, 265, 267, 268, 269 
Glyceraldehyde 3-phosphate 
Pasteur effect and, 290, 291 
phosphorylation potential and, 244-245 
Glyceraldehyde-3-phosphate dehydrogen­
ase 
GTP assay and, 208 
inorganic phosphate assay and, 212 
Glycerol, storage o f mitochondria and, 31, 
32 
Glycerol gradient, ATPase purification and, 
356 
α-Glycerophosphate 
assay of, 221 
measurement of H +/site ratios and, 648 
phosphorylating vesicles and, 166 
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GIycerol-3-phosphate dehydrogenase, brown 
adipose tissue mitochondria and, 75, 
76-77 
Glycogen 
A M P assay and, 209 
assay of, 221 
formation, Pasteur effect and, 295 
isolation of mitochondria and, 37 
phosphate assay and, 212 
Glycolysis, Pasteur effect and, 290, 291 
Goldman equation, diffusion potentials and, 
559 
Goldman-Hodgkin-Katz equation, mem­
brane potential and, 692 
Gramicidin 
bacteriorhodopsin photovoltage and, 754, 
755 
chromatophore planar membranes and, 
756 
M. phlei ETP and, 186 
oxidative phosphorylation and, 451 
photovoltage and, 592, 612 
Gramicidin A, as ionophore, 440-441, 442 
Grind mi l l , disruption of N. crassa cells by, 
145, 146 
Grisor ix in, 446 
Guanidine hydrochloride 
dissociation of F, ATPase subunits and, 
354-355 
dissociation of TF, by, 784 
Guanosine diphosphate, brown adipose tis­
sue mitochondria and, 16, 71, 72-73 
Guanosine triphosphate 
assay of, 208, 221 
ATP-Pj exchange preparation and, 361 
brown adipose tissue mitochondria and, 
71 
complex V and, 314 
F, ATPase and, 328 
separation of, 287, 288 
Guinea pigs, brown adipose tissue in , 66, 67 
Gummifer in, see Carboxyatractyloside 
Η 
Halobacterium halobium 
cells, internal volume, 551 
Dio-9 and, 515 
envelope vesicles 
assay of electrical potentials across. 612 
external membrane potential probes, 
559 
internal volume, 551 
membranes, optical probes and, 573 
Halophenols, as uncouplers, 470 
Hamsters, brown adipose tissue i n , 66, 67 
Hansch-type equations, uncouplers and, 
466, 469 
Harmines, as optical probes, 573 
Heart, ee also Beef heart, Rat heart 
carnitine i n , 221 





metabolite contents of, 216 
mitochondria, 13-14 
ATPase of, 298, 299, 300 
isolation from small amounts of tissue, 
39-46 
oligomycin-sensitive ATPase of, 303 
properties, 14 
storage of, 31 
optical probes and, 573, 580 
Heat treatment, of ATPase inhibitor, 410-
411 
Hematoporphyrin-imidazole, light-driven 
electron transfer between, 537 
phosphorylation and, 540 
Heme, Keilin-Hartree preparation and, 123 
Heparin, isolation of mitochondria and, 4, 
13 
Hepatocytes 
distribution of pyridine nucleotides in , 215 
metabolite distribution in , 214 
/?-Heptylquinoline /V-oxide, cytochrome b 
- ci region and, 461-462 
bis(Hexafluoroacetonyl)acetone 
complex V and, 315 
synthesis of, 470 
uncoupling activity, 465 
Hexokinase 
A M P assay and, 209 
GTP assay and, 208 
inorganic phosphate assay and, 212 
Pasteur effect and, 291 
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oxidative phosphorylation assay and, 723, 
724, 747 
P/0 ratio and, 226 
succinyl-Co A assay and, 210 
Hexylamine, measurement o f ΔρΗ and, 562 
High-performance liquid chromatography, 
o f aureovertins, 480 
Homogenization 
o f arteries and veins, 61 
of heart tissue, 42 
of hepatoma tissue, 86 
isolation of mitochondria and, 4-5 
preparation o f mitochondria and, 116-117 
of rat l iver, 34-35 
Homogenizer, see also Sonifier 
Braun, 152, 154, 162, 416 
Dounce, 4, 52, 54 
Dyno Mi l l K D L , 155, 156 
Gaul in-Mantin, 416 
Kontes Glass Co., 47 
Poly i ron , 4, 61 , 202 
Potter-Elvehjem, 4, 34, 54, 56, 61, 62, 99, 
155 
Tekmar, 385 
Waring Blendor, 158, 161 
Human heart, mitochondria, characteristics 
of, 45 
Hydrazine, transhydrogenase and, 268, 270 
Hydrogen ions, see also Protons 
bacteriorhodopsin and, 592, 594 
electrochemical potential outside mem­
brane, 227 
gradient, evaluation of, 227-229 
oxidative phosphorylation and, 226-227 
Pasteur effect and, 295 
stereospecific transfer between pyridine 
nucleotides, 274-275 
Hydroxyapatite 
purif ication o f ATPase subunit 1 and, 
355 
purif ication o f subunit 2 on, 355 
transhydrogenase and, 278-279 
3-Hydroxybutyrate 
brain mitochondria and, 57 
hepatoma mitochondria and, 81 , 82, 83 
oxidation, characteristic - » H + / 0 values 
and, 638 
3-Hydroxybutyrate dehydrogenase, hepa­
toma mitochondria and, 82 
25-Hydroxycholecalciferol, kidney mito­
chondria and, 11-12 
Hydroxylamine, M. phlei membrane sys­




Imidazole, uptake, pH change and, 564 
Immunological assay, o f mutant ATPase, 
802 
Immunoprecipitation 
of ATPase complex, 346-347 
isolation of mitochondrial components 
and, 148 
Incorporation procedure, reconstitution 
studies and 
with detergents, 707, 709 
without detergents, 708-709 
Inhibitor(s), see also Uncouplers 
ATPase assays and, 329 
E. coli ATPase and, 796 
of M. phlei membrane systems, 185-186 
miscellaneous, 515-518 
Inner filter effect, optical probes and, 576 
Inosine triphosphate 
ATP-Pj exchange preparation and, 361 -
362 
complex V and, 314 
F, ATPase and, 328 
separation of, 287 
Insect(s), flight muscles, mitochondria of, 
22-24 
Integrity, mitochondrial 
P/O ratio and, 8-9 
respiratory control ratio and, 8 
Intrinsic membrane protein 
of M. phlei, 188 
purification of, 195 
Iodoacetic acid, 517 
Ion(s) 
distribution 
determination of ΔρΗ across mem­
branes and, 561-563 
determination without separation, 556 
equil ibrium distribution, determination by 
separation techniques, 552-556 
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permeable, electrochemical equilibrium 
distr ibution, 548-549 
Ionophores 
bioenergetic systems and, 450-454 
carboxyl ic, cation fluxes and, 674-675 
classification and cation selectivity, 440-
448 
general use of, 448-450 
model transmembrane redox reactions 
and, 542-544 
nature of, 435-438 
synthetic, 443 
as uncouplers, 471-472 
Ionophorous activity, assessment of, 438-
440 
Ion permeabilities, brown adipose tissue 
mitochondria and, 72 
Ion transport, by smooth muscle mitochon­
dria and, 65 
Iron 
ATPase and, 301 
complex V and, 315 
Irradiat ion, o f M. phlei ETP, 185 
Ischemia, rat heart metabolites and, 217 
4-Isobutyl-2,6-dinitrophenol, 470 
Isocitrate 
assay, improvements in , 206 
content 
o f brain, 218 
o f kidney cortex, 220 
o f rat heart, 216 
intact mitochondria and, 143 
measurement of proton translocation and, 
638 
Isocitrate dehydrogenase 
citrate assay and, 211 
inhibit ion of, 206 
pyridine nucleotide assay and, 264, 265, 
267, 268, 269 
Isocitrate dehydrogenase (NAD) , brain mi­
tochondria and, 58 
Isocitrate dehydrogenase (NADP) , brain 
mitochondria and, 58 
Isoelectric focusing 
o f ATPase inhibitor, 424-425 
proline carrier protein and, 196 
Isoelectric point(s), of ATPase inhibitors, 
402, 413-414, 426 
4-Isoocty 1-2,6-dinitrophenol, 470 
Isotopic Ca 2 + - jump procedure, measure­
ment of Ca 2 +/site ratios and 
apparatus, 650-651 
calculations, 652 
components of system, 651 
procedure, 651-652 
Κ 







improvement of, 206 
content 
of brain, 218 
of hepatocytes, 214 
of kidney cortex, 220 
of rat heart, 216, 217 
of rat liver, 213 
rat brain mitochondria and, 57 
yeast mitochondria and, 150 
a-Ketoglutarate dehydrogenase 
brain mitochondria and, 58 
coenzyme A assay and, 209 
Ketone bodies 
brown adipose tissue mitochondria and, 
76 
liver mitochondria and, 21 
Kidney cortex 
metabolite content of, 220 
mitochondria of, 11 
properties, 11-12 
Kinetics, o f proteoliposome incorporation 
into planar membranes, 768 




assay of, 221, 294 
content o f kidney cortex, 220 
flow dialysis experiments and, 683 
Pasteur effect and, 290, 294, 295 
phosphorylating vesicles and, 166 
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Lactate dehydrogenase 
AMP assay and, 208 
ATPase assay and, 313, 320, 329 
ATPase inhibitor assay and, 408 
brain mitochondria and, 58, 59 
pyridine nucleotide assay and, 264, 265, 
267, 268, 269, 273, 276 
rhein and, 459 
Laidlomycin, 446 
Lanthanum ions, bacteriorhodopsin photo­
voltage and, 754-755, 768 
Lapachol, Μ. phlei membrane systems and. 
186 
Lasalocid 
code number, 445 
homologs of, 446-447 
as ionophore, 443, 446 
solutions of, 448 
structure of, 437 
Lauryldimethylamine oxide, bacteriochlo-
rophyll proteoliposomes and, 760 
as ionophore, 443, 448 
Leci thin, see also Phosphatidylcholine 
bacteriorhodopsin sheets and, 601 
unsaturated, transhydrogenase and, 814— 
815 
Lenoremycin, 446 
code number, 445 
Leucinostatin 
availability and preparation, 513 
biological properties, 513-514 
physical properties, 477 
structure, 512-513 
toxicology, 513 
uncoupling by, 506 
Light-scattering, Crabtree effect and, 297 
Lip id 
Keil in-Hartree preparation and, 123 
piericidin A binding and, 457 
rotenone binding and, 455 
Lipogenesis, glycolysis and, 295 
Lipophi l ic anions, uptake, transhydrogen­
ase assay and, 262, 272-274 
Lipoprotein lipase, muscle mitochondria 
and, 13 
Liposomes 
external membrane potential probes and, 
559 
ionophores and, 439 
in model system for transmembrane redox 
reactions, 541-542 
proteolipid, preparation of, 418 
reconstitution studies and, 707, 708 
Li th ium ions, amino acid transport and, 187 
Liver, see also Rat liver 
carnitine in , 221 
metabolite contents of, 213 
mitochondria 
ATPase of, 299, 300 
properties of, 20-21 
storage of, 31 
Locust, mitochondria of, 24 
Lonomycin, 445. 446 
LSD, as optical probe, 573 
Lubrol WX, ATPase isolation and, 331 
Luciferase 
A M P assay and, 209 
ATP assay and, 539 
Lung, mitochondria, 19-20 
properties, 20 
Lymphocytes, optical probes and, 573 
Lyophil ization, tissue extraction and, 202 
Lysocell in, as ionophore, 446 
Lysolecithin, reconstitution studies and. 
707, 708 
Lysophosphatidylcholine, transhydrogen­
ase assay and, 276 
Lysosomes 
enzymes, bovine serum albumin and, 116 
internal volume, 551 
marker enzyme, 101 
mitochondria and, 117 
Lysozyme 
membrane preparation and, 782 
protoplast ghost preparation and, 181 
Μ 
Macrotetralides, as ionophores, 442, 444 
Magnesium chloride 
adenylate kinase and, 285 
mitochondria and, 7 
Magnesium ions 
A23187 and, 449 
adenylate kinase and, 232 
ATPases and, 301 
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energy charge and, 233-234 
Pasteur effect and, 291 
phosphorylation potential and, 235, 236, 
238, 244 
reconstitution studies and, 708 
role in mitochondria, 453 
smooth muscle mitochondria and, 62, 64, 
65 
Malaie 
assay of, 206-207, 221 
coenzyme A assay and, 210 
content 
o f brain, 218 
of hepatocytes, 214 
of kidney cortex, 220 
o f rat heart, 216, 217 
of rat l iver, 213 
intact mitochondria and, 143 
mitochondrial incubation and, 8 
rat brain mitochondria and, 57 
yeast mitochondria and, 150 
Malate dehydrogenase 
citrate assay and, 211 
coenzyme A assay and, 210 
α-ketoglutarate assay and, 206 
matrix and, 101, 104 
assay of, 102 
mitochondrial subfractions and, 94, 99 
oxaloacetate assay and, 207 
rhein and, 459 
Malate dehydrogenase (NAD) , brain mito­
chondria and, 58 
Malate-vitamin Κ reductase, M. phlei ETP 
and, 184, 185, 186 
Malic enzyme, steroid hydroxylation and, 
10 
Malonate, submitochondrial particles and, 
107 
Malononitr i le, purification of, 470 
Mammary gland, mitochondria of, 19 
Manganese ions, binding to ATPase, 301 
Mannito l , for isolation of mitochondria, 3 
Matr ix , marker enzyme, 101 
McNe i l 4308, as ionophore, 443, 448 
Media 
for growth of C. arbuscula, 479 
for growth of E. coli, 790, 802 
for growth of M. phlei, 178-179 
for growth of S. mobaraensis, 457-458 
for isolation of mitochondria 
possible additions, 4 
principle osmotic support, 3-4 
for microorganismal mitochondria, 142 
for N. crassa culture 
for flux and electrical studies, 658 




bilayer, ionophores and, 439 
biological, ionophores and, 439-440 
components other than ATPase, inhibi­
tors interacting w i th , 495-515 
extraction of TF , from, 782 
mitochondrial, separation of, 88-98 
optimal ratio to probes, 580 
planar 
chromatophore photosynthetic redox 
chain and, 756 
cytochrome oxidase containing, 755-
756 
made of a mixture of phospholipid, pro­
tein and decane, 751-752 
proteoliposomes and, 756-757 
planar black, association of bacteriorho­
dopsin sheets w i th , 772 
planar phospholipid, proteoliposomes as­
sociated w i th , 763, 766-768 
release of ATPase from, 803 
thickness, equation for, 608 
Membrane factor 
covalent binding to collagen membrane 
and reassociation with F j , 744-746 
preparation of, 742-744 
Membrane fragments, of M. phlei, 195-196 
Membrane particles, ATPase-depleted, 
preparation of, 796-797 
Membrane potential 
brown adipose tissue mitochondria and, 
72 
definition of, 547 
determination, 556-557 
extrinsic probes, 558-559 
intrinsic probes, 557-558 
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light-dependent, assay of, 779-780 
measurement of, 451-452 
optical probes as monitors, 569-570 
calibration, 581-585 
conclusions, 585-586 
probe selection, 570-574 
probe sources, 574 
technique and instrumentation, 574-581 
protein-produced 
apparatus, 588-589 
applicability to natural membrane ves­
icles, 595-596 
applicability to reconstituted systems, 
595 
electrolyte solutions, 589 
estimation of electromotive force and 
equivalent electric scheme, 592-
595 
filters, 589 
phospholipid treatment of fi lters, 589 
principle. 588 
protein incorporation, 589-591 
rate of potential generation, 592-595 
stability o f system, 591-592 
reconstitution and, 586-603 
synthetic penetrating ions as probes in 
proteoliposomes, 763 
transport-l inked, 656-657 
culture media, 657-658 
electrophysiological techniques, 658-
662 
flux techniques, 663-666 
typical values, 555 





optimization of procedure, 690-691 
other classes of dyes, 694-695 
precautions, 692-694 
reagents, 690 
reversibil ity, 691 
studies w i th single cells, 695 






regeneration systems, 710-711 
sonication, 704-707 
Membrane proteins, reconstitution of elec-
trogenic function 
association of bacteriorhodopsin sheets 
wi th planar black membranes, 772 
planar membranes made of a mixture o f 
phospholipid, protein and decane, 
751-772 
proteins situated on the hydrocarbon/ 
water interface, 773-776 
Membrane resistance, measurement of, 661 
Membrane vesicles 
colicins and, 536 





preparation of, 359-360 
Menaquinone 
M. phlei ETP and, 184, 185 
protoplast ghosts and, 182 
2-Mercaptobenzothiazole, plant mitochon­
dria and, 24 
Merocyanine(s) membrane potentials and, 
559, 571, 573 
Merocyanine-540, membrane potential and, 
694 
Metabolic processes, cyanine dyes and, 693 
Metal ions, ATPases and, 301 
Methanol 
ionophores and, 448 
phosphorylating vesicles and, 166 
proteolipid extraction and, 416 
as water space marker, 555 
Methionine, radioactive aureovertin and, 
480-481 
Methylamine, measurement of ΔρΗ and, 
562, 563 
Methyl Cellosolve, as uncoupler solvent, 
464 
Methylene blue, M. phlei membrane sys­
tems and, 186 
/V-Methylphenazine, ferricyanide and, 543-
544 
Meyerhof quotient, Pasteur effect and, 292-
293 
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Micrococcus lysodeikticus. ATPase and, 
341 
Microelectrodes 
electrophysiological techniques and, 660-
661 
insertion into hyphae, 661-662 
Micromanipulators, electrophysiological 
techniques and, 660 
Microorganisms, isolation and characteri-
zation of mitochondria from 
controlled breakage of organisms, 135-
142 
criteria of integrity, 143-144 
preparation of subcellular fractions, 142-
143 
Microsomes 
isolation of, 101 
marker enzymes, 101 
Millipore filters 
lipid-impregnated 
assay of ionophore activity and, 419-
420 
preparation of, 605-608 
reconstitution and membrane potential 
and, 589 
separation of cells from medium by, 204 
separation of organelles and, 556 
Mitochondria 
of adipose tissues 
brown, 16-17 
white, 15-16 
adrenal cortex, 9-10 
properties, 10-11 
ATPase inhibitors, 408-414, 421-426 
applications, 407 
properties, 399-407 
ATP-dependent functions, resolution and 
reconstitution, 736-741 
ATP synthesis, potassium ion gradients 
and, 666-675 
aureovertin inhibitory effects 
energy-conserving systems, 482-483 
soluble ATPase, 481-482 
beef heart 
ATPase inhibitor of, 402, 404, 405 
aureovertin and, 482 
DCCD-binding protein from, 428-429 
improved method for ATPase isolation, 
317-319 
isolation of, 385 
preparation in high yield, 46-50 
preparation of ATPase by chloroform 
method, 338-341, 342 
preparation of ATPase from, 304-308 
preparation of rutamycin-sensitive 
ATPase from, 315-317 
purification of transhydrogenase f rom, 
276-283 
reconstitution of ATP synthetase, 711 -
715 
reconstitution o f pyridine nucleotide 




of brown adipose tissue, 65-66 
appearance, 67-68 
ATP synthesis, 77-78 
BSA and, 70 
carnitine and ATP effects, 74 
coupling, 70 
fatty acid content, 75 
fatty acid oxidation, 75-76 
glycerol-3-phosphate oxidation, 76-77 
isolation procedure, 68-69 
of brown adipose tissue 
location of tissue, 66-67 
other substrates, 77 
pattern of substrate oxidation, 75 
pH effects, 70 
phospholipid content, 78 
purine nucleotides and, 70-74 
requirement for K C l , 69-70 
source of tissue, 66 
calculation of —> H + / 0 values and essen-
tial controls, 635-637 
Crabtree effect and, 297 
Dio-9 and, 514-515 
D N A of, 9 
estimation of proton-motive force in , 567-
569 
general properties 
criteria of integrity, 8-9 
incubation medium, 7-8 
substrate permeases, 9 
high-yield and large scale preparation 
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isolation from nuclear fraction, 35-37 
preparation of rat liver homogenate, 
33-35 
purification from postnuclear superna­
tant, 37-38 
storage, 38-39 
yield and characterization, 39 
human heart, characteristics of, 45 
inhibitory effects of citreovir idin, 487, 488 
of insect flight muscle, 22-24 
internal volume, 551 
ionophores and, 440, 447, 449, 450-451, 
452-453 
isolation and characterization from micro­
organisms 
controlled breakage of organisms, 135— 
142 
criteria o f integrity, 143-144 
preparation o f subcellular fractions, 
142-143 
isolation and relevant properties, K + gra­
dients and, 667-668 
isolation from brain, materials and meth­
ods, 51-52 
isolation from small amounts o f heart tis­
sue, 39-40 
characterization, 45-46 
cleaning o f glassware, 41 
equipment, 40 
glassware and tools, 40-41 
handling o f tissue, 41-42 
homogenization, 42 
isolation medium, 41 
separation and washing, 42-45 
stock solutions, 41 
of kidney cortex, 11 
properties, 11-12 
leucinostatin and, 513 
of l iver, 20-21 
long-term storage 




of lung, 19-20 
of mammary gland, 19 
measurement of Ca + +/site ratio in , 649-
650 
isotopic Ca + + - jump procedure, 650-652 
simple steady-state rate method, 652-
655 
simultaneous determination of Ca + + / 
site, H +/site and H + / C a + + ratios, 
655-656 
measurement o f ΔρΗ in , 563 
membranes, optical probes and, 573 
membrane potentials, 555 
extrinsic probes, 559, 560 
Morris hepatoma, isolation and proper­
ties, 79-88 
of neoplastic tissues, 22 
of Neurospora crassa, 25-26 
ATPase complex of, 344-351 
preparation of, 144-148 
nicotinamide nucleotide transhydrogen-
ase i n , 263 
nonsynaptic, preparation of, 52-53 
organotins and, 508-509 
ossamycin and, 512 
phosphorylation potential measurement 
w i th , 237-239 
plant, 24-25 
preparations, measurement o f proton 
translocation and, 633-634 
preparation from N, crassa 
cultivation o f cells, 144-145 
disruption of cell walls, 145-147 
isolation, 147 
properties of, 147-148 
preparation from yeast, 149-151, 160-161 
enzymatic method, 157-159 
large scale method, 155-157, 161-162 
small scale methods, 152-155, 162-163 
preparation of outer membrane from pig 
heart, 98-99 




differential centrifugation, 5-6 
f i l trat ion, 5 
gradient centrifugations, 6 
homogenization, 4-5 
isolation medium, 3-4 
physiological state o f organism, 3 
storage, 6-7 
proton/site ratio o f electron transport, 
641-642 
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calculations, 645 
comments, 645-646 
modified oxygen pulse procedure, 642-
643 
procedure, 643-645 
procedure with C a + + , 648-649 
procedure using K + (plus valinomycin), 
647-648 
reagents and test medium, 643 
steady-state method, 646-647 
rapid separation from medium, 228-229 
rat brain 
preparation of two populations of syn­
aptic and one population of non-
synaptic, 53-56 
properties of four populations of syn­
aptic and nonsynaptic, 56-60 
rat liver 
ATPase inhibitor of, 402, 405, 408-414 
aureovertin and, 482 
electrogenicity of calcium translocation 
in , 639-640 
internal volume, 551 
isolation of oligomycin-sensitive ATPi-
ase from, 328-333 
membrane potential, 555 
purification of F, ATPase from, 320-
328, 333-337 
reconstitution of ATP-dependent func­
tions, 736-741 
respiratory carriers, measurement of pro­
ton translocation and, 623-627 
separation 
into acid, 204-205 
into alkali , 205 
of intermembrane components, 91-93 
separation of membranes 
analyses, 90-91 
general principles, 90 
reagents and solutions, 90 
separation of outer membrane compo­
nents, 91 
smooth muscle, 14-15 
content and yield, 62 
isolation, 60-61 
properties, 62-65 
of spermatozoa, 21-22 
of spleen, 21 
stabilization of function, 115-116 
criteria o f pur i ty , 117-118 
experimental techniques, 116-117 
storage of, 31 
testicular, 11 
of thymus gland, 19 
of thyroid gland, 18 
volume changes, recording of, 668 
yeast 
ATPase isolation by chloroform method, 
341, 342 
enzymatic preparation, 157-159 
isolation, 26-27 
large scale preparation, 161-162 
mechanical preparation, 151-157 
promitochondria and, 28 
properties of, 27-28 
small scale preparation, 162-163 
Mitomycin C, colicin Κ preparation and, 
534 
Mitoplasts 
physically prepared, characteristics of, 98 
rat heart, structure of, 97 
rat liver, structure of, 96 
separation of, 91 
structure of, 95 
Mixing chamber, continuous-flow pH meas­
urement and, 621 
Monactin 
as ionophore, 442 
structure of, 436 
transport and, 680 
Monazomycin, as ionophore, 441, 442 
Monensin 
code number, 445 
as ionophore, 442, 446 
solutions of, 448 
Monoamine oxidase 
assay of, 101-102 
hepatoma mitochondria and, 81, 82, 88 
outer membrane and, 101, 103, 104 
release from outer membrane, 91, 93, 94 
Morpholine, uptake, p H change and, 564 
Morris hepatoma 





isolation of mitochondria using proteo­
lysis 
assay procedures, 81 
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enzymatic properties, 82-84 
principle, 79-80 
procedure, 80-81 
Motor, continuous-flow p H measurement 
and, 619 
Mouse brain, metabolite content of, 218-219 
Muscle 
smooth, mitochondria of, 14-15, 60-65 
striated, mitochondria of, 12-13 
Mutants, ATP-Pj exchange and, 362-363 
Mycobacterium phlei membrane structures, 
175-178 
assay for coupling factor activity, 190-191 
assay for latent ATPase activity, 191-192 
assay of transport wi th intact cells, 179— 
180 
amino acid transport in proteolipo-
somes, 197-200 
comparison of active transport by ghosts 
and ETP, 186-187 
growth media, 189-179 
inhibitors, 185-186 
membrane fragments, 195-196 
preparation and properties of depleted 
ETP, 187-188 
preparation and properties of detergent-
treated ETP, 192-193 
preparation and properties of ETP, 182— 
185 
preparation and properties o f protoplast 
ghosts, 180-182 
purif ication o f BCF, by affinity chroma­
tography, 189-190 
purification o f coupling factor-latent 
ATPase, 189 
purification o f intrinsic membrane pro­
tein, 195 
purification of proline carrier protein, 196 
reconstruction o f proline transport, 197 
solubilization and purification of DCCD-
sensitive latent ATPase, 193-195 
summary o f types, 198 
summary o f reconstitution of functions, 
199 
Myel in, preparation o f brain mitochondria 
and, 55 
Myof ibri ls , ATPase inhibitor of, 402 
Myoglobin, Keil in-Hartree preparation and, 
119, 120 
Myosin, heart mitochondria and, 47 
Ν 
Nactrin, homologs, as ionophores, 444 
Nagarse, mitochondria and, 8, 13, 14, 15, 
41 , 42, 61 , 80 
Naphthalene sulfonates 
as optical probes, 573 
purification of, 574 
1,4-Naphthoquinone, chromatophore planar 
membranes and, 756 
1,4-Naphthoquinone 2-sulfonate, reduced, 
proton translocation and, 751 
/V-(l-Naphthyl) ethylene diamine, measure­
ment o f pH changes and, 564-565 
Narasin 
code number, 445 
as ionophore, 443 
Nbf-Cl 
biological properties, 489-491 
chemical properties, 489 
physical properties, 4^6 
NCCD, see Carbodiimide 
Nectin, properties of, 397 
Neoplastic tissues, mitochondria of, 22 
Nernst equation 
diffusion potentials and, 558, 559 
optical probes and, 583 
Neurospora, calibration of optical probe re­
sponse in , 581-582 
Neurospora crassa 
disruption of, 139, 145-147 
mitochondria, 25-26 
cultivation of cells, 144-145 
disruption of cell walls, Ί45-147 
isolation of, 147 
properties of, 147-148 
mitochondrial ATPase complex 
immunoprecipitation of, 346-347 
preparation o f antiserum, 345-346 
principle, 344 
properties, 347-351 
purif ication, 344-345 
transport linked to membrane potential i n , 
656-657 
culture media, 657-658 
electrophysiological techniques, 658-
662 
flux techniques, 663-666 
Neutral ligand of Simon et al., as ionophore, 
443 
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Neutral red, as internal pH indicator, 565-
566 
Nicotinamide adenine dinucleotide, see also 
Pyridine nucleotide(s) 
amino acid transport and, 187 
ammonia assay and, 209 
AMP assay and, 209 
assay of, 221 
brown adipose tissue mitochondria and, 
69 
citrate assay and, 211 
coenzyme A assay and, 210 
content 
brain, 219 
of rat heart, 217 
of rat l iver, 213 
mammalian mitochondria and, 8 
M. phlei ETP and, 184, 185 
M. phlei membrane fragments and, 196 
oxaloacetate assay and, 207 
oxidation 
characteristic - » H + / 0 values for, 638 
inhibitors of, 455-460 
phosphorylating vesicles and, 167 
phosphorylation potential and, 240 
reduction 
ATPase inhibitor and, 407, 412 
coupling factor Β and, 384 
Nicotinamide adenine dinucleotide-cyto-
chrome c reductase 
rotenone-insensitive, outer membrane 
and, 101, 102, 103, 104 
rotenone-sensitive, inner membrane and, 
101, 102, 103, 104 
submitochondrial particles and, 109 
Nicotinamide adenine dinucleotide dehy­
drogenase 
Keilin-Hartree preparation and, 126, 127 
rotenone binding by, 455 
Nicotinamide adenine dinucleotide oxidase 
inhibition of, 266 
Keilin-Hartree preparation and, 121, 124, 
125 
submitochondrial particles and, 109, 110, 
111, 112 
vesicles and, 168 
Nicotinamide adenine dinucleotide phos­
phate 
A M P assay and, 209 
assay of, 221 
citrate assay and, 211 
content of rat liver, 213 
glutamine assay and, 209 
GTP assay and, 208 
inorganic phosphate assay and, 212, 215 
Nicotinamide adenine dinucleotide phos-
phate-adrenoxin reductase, adrenal 
cortex mitochondria and, 10 
Nicotinamide adenine dinucleotide phos-
phate-cytochrome c reductase 
microsomes and, 101, 103 
assay of, 102 
outer membranes and, 103, 104 
Nicotinamide nucleotides 
intact mitochondria and, 143 
N. crassa mitochondria and, 147 
Nicotinamide nucleotide transhydrogen-





assay of, 726-728 
properties, 728, 729 
reconstitution of, 716 
enzyme preparations, 263 






anion transport and, 453 
cation fluxes and, 674, 675 
chemiosmotic hypothesis and, 451 
code number, 445 
complex V and, 315 
flow dialysis experiments and, 683 
as ionophore, 442, 446 
measurement of proton translocation and, 
637 
model redox reactions and, 543 
M. phlei ETP and, 186 
photophosphorylation and, 452 
regenerating systems and, 710 
solutions of, 448 
structure of, 437 
7-Nitrobenzofurazan, derivatives, proper­
ties of, 489 
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Nitrophenols 
solubility of, 463 
as uncouplers, 470 
p-Nitrophenyl acetate, hydrolysis, rapid 
mixing device and, 246 
Nonane-4,6-dione, 517 
Nonheme iron 
Keil in-Hartree preparation and, 123 
M. phlei ETP and, 185 
succinate dehydrogenase and, 700 
2-/;-Nonylhydroxyquinoline /V-oxide, M. 
phlei membrane systems and, 185 




Nuclear magnetic resonance, 1 8 0 measure­
ments and, 252 
Nucle i , preparation of, 36 
Nucleoside diphosphates, ATP-Pj exchange 
preparation and, 362 
Nucleoside diphosphokinase, assay of, 287-
289 
5'-Nucleotidase 
perchloric acid and, 201 
viscosity barrier centrifugation and, 133, 
134 
Nucleotides 
rapid labeling probes, 245-246 
separation of, 251-252 
tightly bound, rate and extent of labeling, 
248-249 
Nupercaine, phospholipase and, 6, 32 
Nystatin 
Donnan potential and, 584 
phospholipid bilayers and, 766 
Ο 
Observation unit , continuous-flow pH 
measurement and, 621-622 
Octadecylamine, planar black membranes 
and, 772 
Octyl dinitrophenol, uncoupling activity, 
465 
Octylguanidine, 516 
Oleic acid, uncoupling activity, 465 
Oleoyl phosphate, ATPases and, 343 
Oligomycin 
A E particles and, 386, 390 
ATPase assays and, 329-330, 333 
ATPase inhibitor and, 407 
ATP synthesis and, 118, 671, 672 
biological properties, 503-504 
brown adipose tissue mitochondria and, 
71-72 
electron flow and, 242 
exchange reactions and, 285, 287 
measurement of Ca 2 +/site ratio and, 650 
M. phlei membrane systems and, 185 
N. crassa mitochondria and, 147 
preparation of, 502-503 
proteolipid ionophore and, 419 
stability, 503 
structure, 501-502 
submitochondrial particles and, 106, 108, 
110, 111 
toxicology, 503 
Oligomycin A, physical properties, 476 
Oligomycin B. physical properties, 476 
Oligomycin C, physical properties, 477 
Oligomycin D, physical properties, 477 
Oligomycin-sensitive adenosine triphospha­
tase, 302-303 
composition of, 303 
o f rat liver mitochondria, 328-329 
analytical procedures, 329-330 
isolation procedures, 330-332 
properties, 333 
stability, 333 
reconstitution of, 703, 704 
yeast, 351 
assay method, 352 
properties of Fi ATPase, 353-354 
properties of F , subunits, 356 
properties of oligomycin-sensitive 
ATPase, 356-358 
purification of F j ATPase, 352-353 
purification of F j subunits, 354-355 
purification of sensitive ATPase, 356 
subunits of, 358 
Oligomycin-sensitivity-conferring protein, 
391-392 
assay of, 392-393 
it is the stalk, 397 
properties of, 381, 382-383, 396-397 
removal of, 112 
Organelles, internal volumes of, 551 
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Organism(s), physiological state, mitochon-
dria and, 3 
Organotins, see also Tr iethyl- , Tr imethyl-
availabil i ty, 507 
relative inhibitory potencies, 510 
structure, 507 
toxic i ty of, 508 
OSCP, see Oligomycin-sensitivity-confer-
ring protein 
Osmolal i ty , internal volume and, 550 
Osmotic swelling, uncouplers and, 463 
Ossamine, structure, 511 
Ossamycin 
availability and preparation, 512 





cycl ing method, 207 
radiometric method, 208 
coenzyme A assay and, 210 
content 
o f brain, 218 
o f hepatocytes, 214 
of kidney cortex, 220 
o f rat heart, 216, 217 
o f rat l iver, 213 
Oxidat ion, coupling to phosphorylation, 
model reactions, 536-540 
Oxidative phosphorylation 
assay for, 153, 155 
in intact cells, 169-174 
in phosphorylating vesicles, 166-167 
ATPase inhibitor and, 401, 404, 406 
Oxidative phosphorylation 
hepatoma mitochondria and, 82, 83 
measurement, 164, 175 
cult ivation of bacteria, 165 
in intact cells, 168-175 
in phosphorylating vesicles, 165-168 
principle, 165 
by N. crassa mitochondria, 147 
rate measurements, 225-227 
reconstitution, 701, 703, 708 
activity of, 703, 705 
site I 
assay of, 723-726 
reconstitution of, 716-722 
properties after reconstitution, 725 
site I I 
assay of, 734 
properties, 734-735 
reconstitution, 732-734 
site I I I 
assay of, 731-732 
properties, 732, 733 
reconstitution of, 728-731 
steady-state measurements, 227-229 
submitochondrial particles, 105 
sonicating medium and, 106 




bleaching of, 574, 576 
membrane potentials and, 559, 571, 573, 
694-695 
Oxygen 
ATP production and, 292 
energy-linked transhydrogenase and, 789, 
790 
fermentation and, 289-290 
flow dialysis experiments and, 686 
measurement of Ca 2 +/site ratio and, 649, 
652 
measurement of proton translocation and, 
631, 633, 634 
M. phlei membrane fragments and, 196 
solubility of, 634, 644 
uptake 
amino acid transport and, 180 
by brain mitochondria, 57 
by brown adipose tissue mitochondria, 
75-76 
hepatoma mitochondria and, 81 , 83 
P/O ratio and, 226 
smooth muscle mitochondria and, 64, 
65 
by yeast mitochondria, 150 
1 8Oxygen exchange 
measurement of 
ATP exchanges, 258 
illustrative calculations, 258-261 
medium Pj ^ H O H exchange, 258 
total Pj ^ H O H exchange, 257-258 
probes of, 252-256 
Oxygen pulse procedure 
for measurement of H +/site ratio 
calculations, 645 




reagents and test medium, 645 
oxidative phosphorylation and, 226-227 
proton translocation and, 750-751 
Ρ 
Palmitoyl carnitine, brown adipose tissue 
mitochondria and, 74, 75-76 
Paper chromatography, o f atractyloside and 
carboxyatractyloside, 521 
Paracoccus denitrificans 
ATPase inhibitor of, 407 
aureovertin and, 483 
Nbf-Cl and, 490 
venturicidin and, 507 
Pasteur effect 
cofactors of phosphorylation system and, 
290-292 
efficiency, factors influencing assess­
ment, 295-296 
historical, 289-290 
quantitation of, 292-295 
PCB, see Phenyldicarbaundecaborane 
PCP, uncoupling activity, 465, 470 
Peliomycin 
oligomycin Β and, 501-502 
physical properties, 477 
Penicillium citreoviridi, citreoviridin prepa­
ration f rom, 486-487 
Penicillium lilacinum, leucinostatin and, 513 
Pentachlorophenol 
complex V and, 315 
M. phlei membrane systems and, 185 
as uncoupler, 470 
3,3',4',5,7-Pentahydroxyflavone, see Quer-
citin 
Peptides, as ionophores, 440-441, 442 
Perchloric acid, concentration for tissue ex­
traction, 201-202 
p H 
ATP-Pj exchange and, 360, 363 
brown adipose tissue mitochondria and, 
70 
measurement by continuous-flow method 
construction scheme, 619-622 
measurement of proton translocation 
associated wi th aerobic oxidation 
of mitochondrial respiratory car­
riers, 623-627 
measurement in stirred suspensions, 616— 
618 
phosphorylation potential and, 236, 238 
transhydrogenase and, 270 
pH changes 
calculation of 
acetate concentration gradient, 687-688 
acetate uptake by vesicles, 686-687 
free acetate in upper chamber, 686 
caused by energized vesicles, 366-367 
cyanine dyes and, 693-694 
determination across membranes 
by change in external concentration, 
563-565 
internal pH indicator, 565-567 
ion-distribution techniques, 561-563 
measurement of, 749-750 
proteolipid ionophores and, 418-419 
pH gradient, imposed, reconstitution of 
ATP synthesis and, 746-748 
pH indicator, internal, 565-567 
pH-recording unit, assembly of, 619 
i>-Phenanthroline, M. phlei membrane sys­
tems and, 185 
Phenazine methosulfate 
carboxamides and, 461 
cytochrome c and, 110 
flow dialysis experiments and, 683, 685, 
686 
Keilin-Hartree preparation and, 126 
Phenyldicarbaundecaborane 
as penetrating ion, 598, 600 
proteoliposomes and, 764, 768 
Phenylglyoxal, 518 
Phenylmethylsulfonyl fluoride 
adenosine triphosphatase isolation and, 
148 
isolation of mitochondria and, 345 
yeast cell disruption and, 416 
Phloretin, cyanine dyes and, 693 
Phosphate 
assay of, 212, 215, 221, 422 
ATPase assay and, 314 
ATPase F! and, 323 
binding to ATPases, 302 
content of kidney cortex, 220 
Crabtree effect and, 296, 297 
ΔρΗ determination and, 229 
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energy charge and, 233-234 
esterified, estimation of, 171-172 
intra- and extramitochondrial, 244 
measurement of proton translocation and, 
636, 642, 644-645 
mitochondrial incubation and, 7 
1 8oxygen content, reactions contributing 
to, 256 
oxygen exchange and, 253-254, 257-258 
Pasteur effect and, 290, 291 
separation 
procedure, 251-252 
reagents and materials, 250-251 
transport, Pasteur effect and, 292 
3 2Phosphate 
cellular, estimation of specific activity, 
172 
equilibration of starved cells w i th , 169 
organic, determination of acid-labile frac-
t ion, 172, 174 
3 3Phosphate, purification of, 311 
Phosphate transporter, reconstituted, 706-
707, 710 
activity of, 705 
Phosphatidylcholine, see also Lecithin 
preparation of, 718 
Phosphatidylethanolamine 
amino acid transport and, 188 
preparation of, 718 
of thermophilic bacterium PS3, 370 
molecular species of, 371 
Phosphatidylglycerol, of thermophilic bac-
terium PS3,370 
molecular species of, 371 
Phosphatidylserine, reconstitution studies 
and, 708 
Phosphoenolpyruvate 
assay of, 221 
content of kidney cortex, 220 
Phosphofructokinase, Pasteur effect and, 
291, 293 
Phosphoglucomutase 
A M P assay and, 209 
inorganic phosphate assay and, 212 
6-PhosphogIuconate, assay of, 221 
3-Phosphoglycerate 
assay of, 221 
phosphorylation potential and, 244-245 
Phosphoglycerate kinase 
GTP assay and, 208 
inorganic phosphate assay and, 212 
1-Phosphoimidazole, formation of, 540 
Phospholipase 
inhibitor of, 6, 32 
microorganismal mitochondria and, 142 
Phospholipase A, amino acid transport and, 
188 
Phospholipids 
bacteriorhodopsin planar membranes 
and, 752 
BCFo-BCF, and, 195 
bilayer membranes, uncouplers and, 466 
complex V and, 314, 315 
composition of brown adipose tissue mi-
tochondria, 78 
cytochrome oxidase vesicles and, 749 
DCCD and, 498 
filter membranes and, 604, 605 
of insect muscle mitochondria, 23 
Keilin-Hartree preparation and, 123 
liposome preparation from, 541-542 
M. phlei ETP and, 185 
oligomycin-sensitive ATPase and, 302, 
332, 358, 713 
penetrating anions and, 601 
preparation of, 608-609, 717-718 
reconstitution procedures and, 370-371, 
701, 702, 704, 705-706, 707, 708, 709 
suspension, preparation of, 311, 316, 364, 
714 
transhydrogenase and, 283 
treatment of filters w i th , 589 
Phospholipid-impregnated filters, for meas-





incubation mixture, 599-600 
penetrating ions, 598-599 
principle, 597 
Phospholipid/protein ratio, transhydrogen-
ase reconstitution and, 813-814 
Phosphorylase a 
A M P assay and, 209 
inorganic phosphate assay and, 212 
Phosphorylation 
by ETP of M. phlei, 183-184 
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by protoplast ghosts, 182 
reconstitution in detergent-treated ETP, 
188, 193 
Phosphorylation potential 
concept and definition of, 235-237 
determination of, 237 
importance of, 239-243 
in intact cells, 243-245 
measurement wi th mitochondrial suspen-
sions, 237-239 
values of, 236 
Phosphorylation system, cofactors, Pasteur 
effect and, 290-292 
Phosphotransacetylase, coenzyme A assay 
and, 210 
Photodetectors, optical probes and, 577 
Photodynamic damage, cyanine dyes and, 
693 
Photophosphorylation, ATPase inhibitor 
and, 404 
Photopotentials 
assay from bacteriorhodopsin-containing 
liposomes, 608-611 
rate of generation, 592 
Photosystem I , proteoliposomes and, 760-
761, 768 
Physarum polycephalum, disruption of, 137 
Pi crate 
complex V and, 315 
ionophores and, 439, 444 
Piericidin A 
isolation of, 457-458 
N A D H oxidation and, 456-458 
Pigments, membrane, as optical probes, 573 
Plants, mitochondria of, 24-25 
Plasma membranes 
assay of electrical potentials across, 612 
isolation of, 36 
Platelets, optical probes and, 573 
Pluronic F-127, dye solutions and, 576 
Polychlorinated biphenyl, sand and, 125-
126 
Polyethers, as ionophores, 442-443, 444-
446 
Polyetherin A , 445 
Poly(ethyleneglycol), ATPase purification 
and, 318, 794, 802, 803-804 
Poly(ethyleneimine)celluIose 
adenylate kinase assay and, 285-286 
ATP-ADP exchange assay and, 285-286 
ATP-Pj exchange assay and, 286-287 
chromatography on, background and gen-
eral principle, 283-284 
nucleoside diphosphokinase assay and, 
287-289 
nucleotide purity and, 379 
Poly(ethyleneimine) paper, ATP assay and, 
539 
Polyethylene sulfonate, isolation of mito-
chondria and, 4 
Polypeptide, mitochondrial, nucleotide 
binding and, 73-74 
Polytomella caeca pringsheim, disruption 
of, 138 
Polyvinylpyrrolidone, plant mitochondria 
and, 24 
P/O ratio 
mitochondrial integrity and, 8-9 
of phosphorylating vesicles, 167 
representative measurements in intact 
cells, 173, 174 
uncoupler assay and, 464 
yeast mitochondria and, 150 
Postnuclear supernatant, isolation of mito-
chondria from, 37-38 
Potassium aspartate, isolation o f mitochon-
dria and, 4 
Potassium chloride 
brain mitochondria and, 17 
brown adipose tissue mitochondria and, 
69-70 
for isolation of mitochondria, 3-4 
lung mitochondria and, 20 
Potassium chloride junct ion , measurement 
of proton translocation and, 633 
Potassium hydroxide, trit iated, preparation 
of, 530 
Potassium ions 
brain mitochondria and, 57, 59 
calibration o f cyanine dye fluorescence 
and, 691 
concentration, proton translocation and, 
643, 647 
electrochemical potential on two sides o f 
membrane, 228 
endogenous mitochondrial, val inomycin-
dependent release, 669-670 
isocitrate assay and, 206 
886 S U B J E C T I N D E X 
liposomes and, 419 
membrane potential and, 229 
M. phlei ETP and, 186 
phosphorylation potential and, 237 
transport, ionophores and, 450 
Potassium ion gradients 
A T P synthesis and, 666-667 
cation fluxes mediated by carboxylic 
ionophores, 674-675 
dependence of energy transduction on 
the gradient, 672-673 
experimental procedure, 667-668 
general features, 669-670 
properties, 670-672 
summary, 675 
yield and reproducibility, 673-674 
endergonic processes and, 666-667 
use to support transport by E. coli mem­
brane vesicles 
comments, 679-680 
general principle, 676-677 
generation of a membrane potential, 
678-679 
potassium-loaded vesicles, 677-678 
preparation of N a + vesicles, 677 
Potential changes, bacteriorhodopsin-me-
diated, light-dependent, 774-775 
Pregnenolone, formation of, 10 
Pressman cell, ionophores and, 438 
Probes 





selection of, 570-574 
sources of, 574 
redistribution across membranes, 585 
Proline 
transport 
colicin and, 536 
reconstitution in detergent-treated ETP, 
197 




detergent-treated ETP, 193 
reconstitution in proteoliposomes, 197— 
199 
Proline carrier protein(s), purification of, 
196 
Promitochondria, o f yeast, 28 
Propionate 
flow dialysis experiments and, 683, 684, 
685 
measurement of ΔρΗ and, 562 
Propionyl coenzyme A, assay of, 211 
l-/?-Propyl-6-hydroxy-l,4,5,6-tetrahydroni-
cotinamide, oxidation by 0 2 , 537 
Protamine sulfate, ATPase purification and, 
326 
Proteases 
microorganismal mitochondria and, 142 
N. crassa mitochondria and, 148 
tissue homogenization and, 4 
Protein(s) 
brain mitochondria and, 58 
determinations, 330 
distribution in mitochondrial subfrac-
tions, 93-94, 103 
hydrophobic, preparation of, 713-714 
incorporation into filters, 589-591 
situated on the hydrocarbon/water inter­
face 
bacteriorhodopsin-mediated, light-de­






synthesis by N. crassa mitochondria, 
147-148 
viscosity barrier centrifugation and, 133, 
134 
Proteolipid 
ATPase, 350, 358 
synthesis of, 351 
dicyclohexylcarbodiimide-binding, 383 
proton ionophore activity, 418-419 
Proteolipid ionophore, o f yeast ATP synthe­
tase, 414-415 
assay procedures, 418-421 
isolation of, 415-418 
Proteoliposomes 
associated with the interface of the bi-
phasic decane plus phospholipid/ 
water system, 769, 772 
associated wi th planar phospholipid mem-
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branes or phospholipid-impregnated 
filters 
applicability, 768 
general remarks, 763, 766-768 
kinetics o f association, 768 
glucose carrier and, 707 
incorporation into filters, 589-591 
planar membranes and, 756-757 




bacteriochlorophyll reaction center 
complex, 760 
bacteriorhodopsin, 758-760 
cytochrome oxidase, 761 
cytochrome oxidase plus bacteriorho­
dopsin, 762 
Η +-ATPase, 761-762 
H + -ATPase plus bacteriorhodopsin, 
762 
H + -ATPase plus cytochrome oxidase, 
762 
photosystem I , 760-761 
principle, 757-758 
reaction center and antenna complexes, 
760 
synthetic penetrating ions as probes for 
membrane potential in , 763 
Protohemin dimethyl ester, preparation of, 
538 
Protons, see also Hydrogen ions 
excretion in urine, 12 
permeability, oligomycin and, 504 
translocation, stoichiometry linked to 
ATP synthesis, 241, 242 
uptake, phosphorylating vesicles and, 168 
Proton-adenosine triphosphatase, proteoli-
posomes and, 761-762 
Proton gradient 
ATPase and, 302 
light-dependent, assay of, 789-780 
uncouplers and, 466 
Proton-motive force 
estimation in mitochondria, 567-569 
importance of, 547 
Proton pump, reconstituted, 710 
activity of, 703, 705, 708 




modified oxygen pulse procedure, 642-
643 
procedure, 643-645 
procedure wi th C a + + , 648-649 
procedure wi th K + (plus val inomycin) , 
647-648 
reagents and test medium, 643 
steady-state method, 646-647 
Proton-transfer reactions, calculation o f re­
action time, 622 
Proton translocation 
by cytochrome oxidase phospholipid ves­
icles, 748 
oxygen pulse experiments, 750-751 
preparation of vesicles, 749 
proton translocation assay, 749-750 
respiratory control , 749 
measurement, 627-628 
calculation of —> H + / 0 values and es­
sential controls, 635-638 
general principles, 628-633 
method, 635 
mitochondrial preparations and re­
agents, 633-634 
scope of stoichiometric —* H + measure­
ments, 638-640 
Protoplasts, yeast, preparation of, 26-27 
Protoplast ghosts 
amino acid transport, comparison to ETP, 
186-187 
of M. phlei 
preparation of, 180-182 
properties, 182 
Prototheca zopfii, disruption of, 138 
Protozoa, disruption of, 135, 136-137 
Pseudomonas cocovenenans, bongkrekic 
acid from, 528 
Purine nucleotides, brown adipose tissue 
mitochondria and, 70-74 
Purple membranes, in corporation into ves­
icles capable o f light-stimulated ATP 
synthesis, 777-780 
Pyridine nucleotide(s), see also Nicotine-
amide 
content of mitochondria, 637 
determination of, 263-267 
distribution between cytosol and mito­
chondria in hepatocytes, 215 
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ratio in mitochondria, 239-240 
redox changes, measurement of, 668 
Pyridine nucleotide transhydrogenase, see 
also Transhydrogenase 




enzyme preparation, 811 
procedure, 812-815 
reconstitution from E. coli, 787-788 
enzyme assays, 788-790 
preparation of ATPase, 790-796 
preparation of stripped membrane par­
ticles, 796-797 
procedure for reconstitution, 797-800 
Pyridoxal phosphate, 517 
Pyronins, as optical probes, 573 
Pyrophosphate, R. rubrum chromatophores 
and, 596 
Pyruvate 
assay of, 221 
content o f kidney cortex, 220 
measurement of H +/site ratios and, 648 
rat brain mitochondria and, 57 
Ν. crassa mitochondria and, 147 
steroid hydroxylation and, 10 
white adipose tissue mitochondria and, 
15-16 
yeast mitochondria and, 150 
Pyruvate dehydrogenase 
brain mitochondria and, 58 
white adipose tissue mitochondria and, 16 
Pyruvate kinase 
A M P assay and, 208 
ATPase assay and, 313, 320, 329 
ATPase inhibitor assay and, 408, 422 
Pasteur effect and, 290-291 
Q 
Queracetin 
cyanine dyes and, 693 
Quercit in 
availabil ity, 491 
biochemical properties, 491-492 
physical properties, 476 
structure, 491 
toxicology, 491 
Quinacrine, submitochondrial particles and, 
112 
Quinol phosphate, oxidation by Br 2 , 537 
Quinones, M. phlei membrane systems and, 
186 
R 
Rabbit skeletal muscle, myofibrils, ATPase 
inhibitor of, 402, 405 
Rapid proton-transfer reactions, electrome-
tric measurement, 614-615 
instrumentation, 615-616 
p H measurement by continuous-flow 
method, 618-627 
pH measurement in stirred suspensions, 
616-618 
Rats, brown adipose tissue in , 66 
Rat brain, metabolite content of, 218-219 
Rat heart 
metabolite contents of, 216 
mitochondria 
aureovertin and, 482 
Rat kidney cortex, metabolite content of, 
220 
Rat liver 
cells, internal volume, 551 
lysosomes, internal volume, 551 
metabolite contents of, 213 
mitochondria 
ATPase inhibitor of, 402, 405, 408-414 
aureovertin and, 482 
electrogenicity of calcium translocation 
in , 639-640 
internal volume, 551 
isolation of oligomycin-sensitive ATP­
ase from, 328-333 . 
membrane potential, 555 
purification of ATPase from, 320-
328, 333-337 
reconstitution of ATP-dependent func­
tions, 736-741 
preparation of homogenate, 33-35 
submitochondrial particles, aureovertin 
and, 482 
Reaction vessel, measurement of proton 
translocation and, 629-631 
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Recorders 
electrophysiological techniques and, 659-
661 
measurement of proton translocation and, 
633 
rapid proton-transfer reactions and, 615-
616 
Recycling method, for enhanced sensitivity 
of enzymatic assays, 215, 217, 221 
Red blood cells 
external membrane potential probes and, 
559 
ionophores and, 439-440, 447 
optical probes and, 573, 582 
resting potential, 692 
Redox potentials, o f ubiquinone and cyto­
chrome c, 240 
Redox reactions, transmembrane, model 
system, 541-544 
Refractometry, determination of protein 
concentration by. 304 
Regeneration systems, reconstitution and, 
710 
Resistance, membrane, measurement of, 
662 
Respiration 
cyanide-insensitive, in N. crassa. 26 
efrapeptin and, 495 
organotins and, 508-509 
uncouplers and, 463 
Respiratory chain 
activity, protontranslocation and, 627-
640 
characteristic - * H + / 0 values of, 637-638 
of M. phlei ETP, 184 
of N. crassa mitochondria, 147 
phosphorylation site of, 240 
Respiratory control 
brown adipose tissue mitochondria and, 
70-72 
of cytochrome oxidase vesicles, 749 
hepatoma mitochondria and, 81 , 83 
rate measurements, 225-227 
steady-state measurements, 227-229 
uncoupler assay and, 464 
Respiratory control ratio 
o f brain mitochondria, 59 
o f hepatoma mitochondria, 82, 83 
microorganismal mitochondria and, 143 
mitochondrial integrity and, 8 
smooth muscle mitochondria, 64, 65 
of stored mitochondria, 30 
of submitochondrial particles, 108 
of yeast mitochondria, 150 
Respiratory rates, of malonate-activated 
ESP, 108 
Resting potential, determination of, 691-692 
Rhein 
isolation of, 459-460 
N A D H oxidation and, 458-460 
Rhodacyanines, as optical probes, 573 
Rhodamine(s), as optical probes, 573 
Rhodamine 6G, 515 
Rh od ops end am ο η a s < apsula ia 
ATPase of, 341, 342 
aureovertin and, 483 
Rhodopsendomonas spheroides 
aureovertin and, 483 
membranes, optical probes and, 573 
Rhodospirillnm rubrum 
ATPase of. 341, 342 
bacteriochlorophyll reaction center, pro­
teoliposomes and, 760 
chromatophores 
aureovertin and, 483 
membrane potential, 555, 559, 595-596 
proton gradient in , 452 
citreoviridin and, 487 
membranes, optical probes and, 573 
transhydrogenase of, 272 
Ribi press, cell disruption by, 803 
Ribonuclease, membrane preparation and, 
803 
Ribosomes 
mitochondrial, from N. crassa, 148 
phosphorylating vesicles and, 168 
Rifampicin, assay of amino acid transport 
and, 179 
Ro 2-2985, 445 
Ro 7-9409, 445 
Ro 20-0006, 445 
Ro 21-6150, 445 
Rose Bengal, as optical probe, 573 
Rotenone 
ATP synthesis and, 452 
coenzyme Q and, 456 
measurement of Ca 2 +/site ratio and, 650 
N A D H oxidase and, 266, 270 
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N A D H oxidation and, 455-456 
N. crassa mitochondria and, 147 
phosphorylation potential and, 238, 239 
yeast mitochondria and, 27 
8 6 Rubid ium, distribution, determination of, 
553-554 
Rutamycin, 477 
ATPase and, 358 
complex V and, 315 




Saccharomyces carlsbergensis, disruption 
of, 141 
Saccharomyces cerevisiae, see also Yeast 
disruption of, 140 
mitochondria, ATPase inhibitor of, 402, 
404, 405 
Safranine, membrane potentials and, 559, 
573 
Salicylanilides, as uncouplers, 467 
Salinomycin, 445 
as ionophore, 442 
Salmonella typhimurium, ATPase, Ε. coli 
stripped membranes and, 800 
Sand 
disruption o f N. crassa cells w i th , 145, 
147 
Keil in-Hartree preparation and, 120, 125-
126 
Sarcina lutea, efrapeptin and, 495 
Sarcoplasmic reticulum 
ionophores and, 454 
phospholipids and, 701 
Schizosaccharomyces pom be, disruption of, 
141 
Scintillation counting, mixture for, 252 
Sedimentation coefficient 
brown adipose tissue mitochondria and, 
69 
viscosity barrier centrifugation and, 129— 
130 
Sennosides, extraction of, 459 
Sephadex 
detergent removal and, 702 
submitochondrial particles and, 111, 112 
Sephadex G-25 
ATPase desalting by, 806 
ATPase inhibitor and, 410 
preparation of F i and membrane factor, 
743 
spin-labeled acyl-atractyloside and, 527 
urea removal and, 797 
Sephadex G-50 
ATPase inhibitor and, 412 
hydroxypropyl , DCCD-binding protein 
and, 432 
nucleotide-depleted ATPase F, and, 378 
reattachment of nucleotides and, 379 
Sephadex G-75, ATPase inhibitor and, 411 
Sephadex G-75-40, coupling factor Β and, 
388 
Sephadex G-100, proline carrier proteins 
and, 196 
Sephadex LH-20, DCCD-binding protein 
and, 429 
Sepharose 4B 
purification of coupling factor and, 189— 
190 
synthesis of succinyl-atractyloside-amino-
Sepharose and, 525 
Sepharose 6B 
preparation of T F 0 F , and, 369 
purification of ATPase and, 791-793, 794, 
804 
TF , purification and, 783 
Sepharose-cytochrome c\ preparation of, 
113-114 
Septamycin, 446 
code number, 445 
1799, see bis(Hexafluoroacetoayl)acetone 
SF6847 
synthesis of, 468-469 
uncoupling activity, 465 
Silica gel 
aureovertin chromatography and, 479, 
480 
4-azido-2-nitrophenylaminobutyrylt-
atractyloside and, 527 
citreoviridin analysis and, 486-487 
efrapeptin purification and, 494 
proteolipid and, 417-418 
venturicidin analysis and, 505 
Silica GF, bongkrekic acid and, 529 
Silicic acid, piericidin A purification and, 
458 
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Silicone oil 
separation o f cells from medium and, 203, 
205, 552 
separation of cytosol and, 243 
separation of mitochondria and, 204, 228, 
229, 239 
Silicotungstic acid particles, 383 
preparation of, 398 
Simon ligand, structure, 441 
Snailgut juice, yeast mitochondria prepara­
tion and, 158, 159 
Sodium bromide 
OSCP preparation and, 394 
preparation of membrane factor and, 744 
Sodium ions 
amino acid transport and, 187, 197, 199 
measurement o f proton translocation and, 
636 
Sodium ion pump, reconstitution, 701, 702, 
704-705, 706, 707 
activity of. 703, 705, 708, 709 
Solutions 
of optical probes, 574, 576 
of uncouplers, 463-464 
Solvents 
for ATP synthetase inhibitors, 475 
for ionophores, 448 
poly(ethyleneimine)cellulose chromatog­
raphy and, 284, 288 
Sonication 
medium, submitochondrial particles and, 
106 
reconstitution o f vesicles and, 372 
Sonication procedure, reconstitution studies 
and 
with freeze-thaw, 707 
without freeze thaw, 704-707 
Sonifier 





Bronwi l l Biosonik, 321, 737 
Heat Systems-Ultrasonic, 305 
Raytheon, 162, 183, 193, 194, 352, 719 
for reconstitution studies, 706 
Tomy probe, 371, 778 
Sorbitol, for isolation o f mitochondria, 3 
Sorbyl coenzyme A, carnitine assay and, 
211 
Soy bean lecithin, see also Azolectin 
liposome preparation and, 418 
proteoliposome preparation and, 197 
Spectrofluorimeter, optical probes and, 577 
Spectrophotometers, optical probes and, 
576-577 
Spectrophotometric constants, pyridine nu­
cleotide analogs and, 271 
Spegazzinine, 515, 516 
Spermatozoa, mitochondria of, 21-22 
Spheroplasts 
preparation, 135, 142 
yeast, formation of, 158 
Spillover, o f radioactivity counts, calcula­
tion of, 554 
Spinach, chloroplasts, ATPase inhibitor of, 
402, 404, 405 
Spleen, mitochondria of, 21 
Stability 
of ATPase, 795 
of Keilin-Hartree preparation, 121 
of membrane-potential-generating sys­
tem, 591-592 
of TF, , 783 
Staphylococcus aureus, efrapeptin and, 495 
Steady-state rate method 
for measurement of Ca 2 +/site ratio 
medium and apparatus, 652-653 
procedure, 653-655 
measurement of H +/site ratios and 
apparatus, 646 
procedure using Ca 2 + , 648-649 
procedure using K + , 647-648 
reagents and medium, 646-647 
Stoichiometric - » H + measurements, scope 
of, 638-640 
Storage, o f mitochondria, 6-7 
Straus and Goldstein, expression of, inhib­
itor data and, 473-474 
St rep toe ο c c u s faecal is 
ATPase of, 298 
Dio-9 and, 515 
membranes, optical probes and, 573 
nectin of, 397 
Streptococcus lactis 
cyanine dyes and, 691 
membranes, optical probes and, 573 
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Streptomyces spp., venturicidin preparation 
f rom, 505 
Streptomyces diastatochromogenes, oligo-
mycins and, 502 
Streptomyces hygroscopicus var. ossamy-
ceticus, ossamycin and, 512 
Streptomyces luteogriseus, peliomycin and, 
503 ' 
Streptomyces mobaraensis, 456 
piericidin A isolation from, 457-458 
Streptomyces rutgersensis, rutamycin and, 
503 
Styryls, as optical probes, 573 
Subcellular fractionation, viscosity barrier 
and, 127-128 
practical procedures, 131-135 
principle, 128-131 
Submitochondrial fractions, procedures for 
pressing and separating, 92-93 
Submitochondrial particles 
affinity chromatography, 114 
depletion of ATPase, inhibitor, 422 
fractionation of, 277 
internal volumes, 551 
measurement of ΔρΗ and, 563 
measurement of Pj ^ H O H exchanges in , 
257 
measurement of proton translocation in , 
637 
preparation of, 114, 393-394 
preparation and extraction of, 719-720 
rate of ATP labeling w i th , 249-250 




tightly coupled of beef heart, 105-106 
activation of succinate dehydrogenase, 
107-108 
ATPase depleted preparations, 110-112 
cytochrome c enriched preparations, 
109-110 
fractionation by density gradient cen-
trifugation, 108-109 
preparation of EDTA particles, 106-107 
Substrate(s) 
o f adrenal mitochondria, 10 
of brain mitochondria, 57 
of brown adipose tissue mitochondria, 
16-17, 75, 77 
concentration, energy charge and, 234 
of E. coli ATPase, 795 
of heart mitochondria, 14 
of insect muscle mitochondria, 23, 24 
of liver mitochondria, 20-21 
of lung mitochondria, 20 
measurement of proton translocation and, 
636 
membrane potential, pH difference and 
phosphorylation potential and, 228 
mitochondrial incubation and, 7-8 
of N. crassa mitochondria, 26 
of plant mitochondria, 25 
of renal mitochondria, 11 
of smooth muscle mitochondria, 15, 64 
of spermatozoan mitochondria, 22 
of spleen mitochondria, 21 
of striated muscle mitochondria, 13 
of thyroid mitochondria, 18 
of white adipose tissue mitochondria, 15-
16 
of yeast mitochondria, 27 
Substrate analogs, transhydrogenase assay 
and, 262, 270-272 
Substrate permeases, of mitochondria, 9 
Substrate-regenerating systems, pyridine 
nucleotide assay and, 262, 267-270 
Subunits 
of ATPases, 298, 299, 324, 347-351, 353 
synthesis, 350 
of E. coli ATPase, 795, 809-810 
of latent ATPase, 192 
of TF , 
properties, 785 
purif ication, 784-785 
reconstitution of T F U 786 
reconstitution of T F o F ^ 786-787 
of T F o - F i , 370 
Succinate 
amino acid transport and, 186-187 
brain mitochondria and, 57 
content 
of brain, 218 
of rat l iver, 213 
cytochrome c reduction by, 110 
growth of E. coli and, 174 
hepatoma mitochondria and, 81, 82, 83, 
87 
measurement of Ca 2 +/site ratios and, 652, 
653, 654 
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measurement of H +/site ratios and, 643, 
645, 647-648, 649 
M. phlei ETP and, 184 
M. phlei membrane fragments and, 196 
N. crassa mitochondria and, 147 
oxidation 
characteristic —» H + / 0 values and, 638 
inhibitors for, 460-461 
phosphorylating vesicles and, 166 
yeast mitochondria and, 150 
Succinate-cytochrome c reductase 
assay of, 102 
Keil in-Hartree preparation and, 126 
Succinate dehydrogenase 
activation, in submitochondrial particles, 
107-108 
Keil in-Hartree preparation and, 124, 125, 
126 
reconstitution and, 699-700 
Succinate oxidase 
irradiation of, 185 
Keilin-Hartree preparation and, 121, 124, 
125 
submitochondrial particles and, 106 
Succinate thiokinase, succinyl-Co A assay 
and, 210 
Succinic semialdehyde dehydrogenase, brain 
mitochondria and, 58 
Succinyl-atractyloside, synthesis of, 524-
525 
Succinyl-atractyloside-amino-Sepharose, 
synthesis and structure of, 525 
Succinyl coenzyme A 
assay of, 210, 211 
content o f rat heart, 216 
Sucrose, for isolation of mitochondria, 3, 6 
Sucrose gradient, purification o f ATPase 
and, 791-793 
Sucrose-impermeable space, intact mito­
chondria and, 143 
Sugars, transport, K + gradient and, 679 
Sulfhydryl compounds, isolation o f mito­
chondria and, 4 
Sulfide 
complex V and, 315 
M. phlei membrane systems and, 185 
Synaptosomes 
isolation of, 55 
mitochondria of, 18 
optical probes and, 573 
preparation of two populations of mito­
chondria f rom, 56 
Synpore filters, membrane potential and, 
589 
Syringe(s) 
collection, continuous-flow pH measure­
ment and, 622 
rapid mixing devices and, 245-246 
reactant 
continuous-flow p H measurement and, 
621 
measurement of proton translocation 
and, 631 
Τ 
Tap water, Keilin-Hartree preparation and, 
119-120, 124-125 
Teflon films, membrane potential and, 589 
Temperature 
colicin action and. 535-536 
phosphorylation potential and, 235, 236 
for storage of mitochondria, 31 
Tentoxin 
availability and preparation, 492 
biological properties, 493 
physical properties, 476 
structure, 492 
Testis, mitochondria of, 11 
Testosterone, synthesis of, 11 
2,4,4',5-Tetrachlorodiphenylsulfone, 515 
3,3' ,4' ,5-Tetrachlorosalicylanilide, proton 
ionophores and, 420 
4,5,6,7-Tetrachloro-2'-trifluoromethylben-
zimidazole, see TTFB 
Tetradifon, 515 
Tetrahymena pyriformis, disruption of, 136 
Tetramethylenephenylenediamine, as elec­






chromatophore planar membranes and, 
756 
model redox reactions and, 542 
Tetranitromethane, 517 
Tetrapentylammonium, as penetrating ion, 
599, 600 
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Tetraphenyl borate 
ionophores and, 439 
as penetrating ion, 598-599 
Tetraphenylboron 
membrane potential and, 678 
transhydrogenase assay and, 273-274, 
811, 814 
uptake of, 168 
Tetraphenylphosphonium, proteoliposomes 
and, 765 
Tetrathionate, carnitine assay and, 211-212 
2-Thenoyltrifluoroacetone, succinate oxi-
dation and, 460-461 
Thermophilic bacterium, culture of, 782 
Thiocyanate 
ionophores and, 439 
measurement of proton translocation and, 
635-636 
Thio ethers, oxidation by I 2 , 537 
Thionicotinamide adenine dinucleotide, 
transhydrogenase assay and, 270-272 
Thymus, mitochondria of, 19 
Thyroid, mitochondria of, 18 
Thyroxine, M. phlei membrane systems 
and, 186 
T in , radioactive, counting of, 508 
Tissue(s) 
metabolite contents of, 222 
perchloric acid extraction of, 201-202 
Tissue grinder, Bolab, 80 
Tolypocladium inflatum, growth conditions, 
494 
TPB, see Tetraphenyl boron 
Transhydrogenase, see also Nicotinamide, 
Pyridine 
ATPase inhibitor and, 407, 412, 413 
brown adipose tissue mitochondria and, 
77 
D C C D and, 499 
energy-dependent, assay of, 789-790 
mitochondrial, rhein and, 459 
phospholipids and, 701 
steroid hydroxylation and, 10 
venturicidin and, 506 
Translocases, of brain mitochondria, 17 
Transport, l inked to membrane potential, 
656-657 
culture media, 657-658 
electrophysiological techniques, 658-662 
flux techniques, 663-666 
Transport selectivities, o f ionophores 
factors affecting, 440 
Trichloroacetic acid, ATPase inhibitor and, 
410, 424 
3,4',5-Trichlorosalicylanilide 
synthesis of, 467 
uncoupling activity, 465 
Tr iethyl t in 
complex V and, 315 
purification of, 507-508 




Trimethylsi lylat ion 
1 8 0 measurements and, 252 
Tr imethyl tin chloride, physical properties, 
477 
Trinuclear heterocyclic dyes, as optical 
probes, 573 
Triosephosphate isomerase, inorganic phos-
phate assay and, 212 
Triphenylmethane dyes, as optical probes, 
573 
Triphenylsulfonium chloride, 516 
Triphenyl tin chloride, physical properties, 
477 
Trw/-propyl tin chloride, physical proper-
ties, 477 
Tr i ton X-100 
ATPase solubilization by, 346, 356 
M. phlei membrane fragments and, 195 
preparation of TF 0 -F ! and, 368-369 
solubilization o f B C F o - B C F i and, 194 
treatment of ETP and, 193 
Trypsin 
ATPase and, 795 
B C F o - B C F j and, 195 
coupling factor and, 189, 191, 192 
treatment of ETP and, 188 
TTB , M. phlei membrane systems and, 185 
TTFB 
synthesis of, 468 
uncoupling act iv i ty, 465 
Tween 80 
growth o f M. phlei and, 179 
M. phlei membrane systems and, 185 
Tyrosine residues 
of ATPases, 299 
4-chloro-7-nitrobenzofurazan and, 490 
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U 
Ubiquinol, oxidation, proton uptake and, 
627 
Ubiquinone, see also Coenzyme Q 
analogs, model redox reactions and, 543 
assay of oxidative phosphorylation at site 
I and, 724 
brown adipose tissue mitochondria and, 
75 
Keilin-Hartree preparation and, 123 
phosphorylation site and, 240 
Ultra Turrax, 4 
Ultrogel AcA 34, ATPase and, 341 
Uncoupler(s) 
activity, comparison of, 464-465 
bacteriorhodopsin-mediated potential 








nifro- and halophenols, 470 
salicylanilides, 467 
complex V and, 315 
Crabtree effect and, 296, 297 
definition of, 462-463 
diffusion potentials and, 584 
hepatoma mitochondria and, 84, 85 




long-chain fatty acids, 472 
macrocyclic antibiotics, 471-472 
of oxidative phosphorylation, 462-463 
assay, 463-465 
types, 466-472 
Pasteur effect and, 290, 293 
reconstituted membranes and, 226 
transhydrogenase and, 815 
Urea 
replacement o f guanidine by, 784 
stripped membrane particles and, 796-797 
submitochondrial particles and, 111, 112 
Urea cycle, l iver mitochondria and, 21 
Urea particles, preparation of, 738, 741 
Uridine diphosphate-glucose, assay of, 221 
Uridine triphosphate 
ATP-Pj exchange preparation and, 361-
362 
complex V and, 314 
separation of, 287, 288 




anion transport and, 453 
ATP synthesis and, 452 
chemiosmotic hypothesis and, 451 
complex V and, 315 
diffusion potentials and, 584 
endogenous K + release and, 669-670 
expulsion of protons and, 367 
flow dialysis experiments and, 683, 685 
as ionophore, 442, 444 
with K + , ions, uncoupling act iv ity, 465 
measurement of proton translocation and, 
628, 635, 637, 642, 643, 647-648 
mode) redox reactions and, 542, 543 
M. phlei ETP and, 186 
proteolipid ionophores and, 419 
regenerating systems and, 710 
solutions of, 448 
structure of, 436 
transport by E. coli membrane vesicles 
and, 676, 679 
use with cyanine dyes, 691 
Veins, isolation o f mitochondria from, 60-
61 
Venturicidin 
analysis of, 505 
ATPase assay and, 329-330, 333 
availability, 505 
complex V and, 315 




N. crassa mitochondria and, 147 
preparation of, 505 
structure, 504-505 
toxicology, 505 
Venturicidin A , physical properties, 477 
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Venturicidin B, physical properties, 477 
Veratridine, cyanine dyes and, 693 
Vesicles 
ATP synthetase, reconstitution of, 715 
energized 
measurement of fluorescence of, 366 
p H changes caused by, 366-367 
formation by cholate-diaiysis technique, 
722-723, 729-730, 733-734 
formation by cholate-dilution technique, 
730-731, 734 
inner membrane, preparation of, 737-738 
internal volumes, 551 
phospholipid, containing complex I and 
ATP synthetase, 716-722 
phosphorylating 
preparation of, 165-166 
properties of, 167-168 
reconstituted 
by dialysis, 371-372 
phospholipids and, 370-371 
properties of, 372 
by sonic oscillation, 372 
Viscosity barrier, subcellular fractionation 
and, 127-128 
practical procedures, 131-135 
principle, 128-131 
W 
Washing, Keilin-Hartree preparation and, 
119-120 
Water 
internal, determination of volume, 549-
552 
oxygen exchange and, 253-254 
Wavelength 
choice of, optical probes and, 578 
cyanine dyes and, 690 
Wurster's blue, Keilin-Hartree preparation 
and, 126 
X 
X-206, as ionophore, 443 
X-464, 445 
X-537A, 445 
X-14547A, structure of, 445 
X-ray diffraction, o f F, ATPase crystals, 
334-337, 343 




culture conditions, 151-152, 155-156, 157 
disruption of, 135, 140-141 
growth and harvest of, 415-416 
mitochondria, 149-151 
ATPase isolation by chloroform method, 
341, 342 
enzymatic preparation, 157-159 
isolation, 26-27 
large scale preparation, 161-162 
mechanical preparation, 151-157 
properties, 27-28 
small scale preparation, 162-163 
oligomycin-sensitive ATPase, 303, 351 
assay method, 351 
properties of F! ATPase, 353-354 
properties of F, subunits, 356 
properties of sensitive ATPase, 356-
358 
purification o f F, ATPase, 352-353 
purification o f Ft subunits, 354-355 
purification of sensitive ATPase, 356 
OSCP of, 397 
promitochondria of, 28 
proteolipid ionophore from mitochondrial 
ATP synthetase, 414-421 
Ζ 
Zincon, 517 
